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ABSTRACT 
 
Chemicals and drugs are known to be metabolized mostly by Cytochrome P450 
xenobiotic metabolizing enzymes. However, the detailed mechanism of nitro-compounds 
metabolism is still unclear. The activation of nitro-xenobiotics by heme-P450 enzymes is 
a potential explanation for the origin of nitro-compound carcinogenesis. Investigating the 
interaction of simple nitro-compounds with redox activity of heme enzymes is therefore 
critical to explore the mechanism and products of activation. 
In this study, multiple analytical methods and instrumentations are employed and 
graphic and simulation software such as Origin® and Digisim® are utilized to 
quantitatively derive parameters from experimental raw data. This study shows that 
myoglobin, iron-protoporphyrin-IX (hemin), and the oxygenase domain of inducible 
nitric oxide synthase (iNOSoxy) act as efficient electrocatalysts for nitroalkane 
reductions in the surfactant films on pyrolytic graphite electrodes. 
In the study using myoglobin as a model electrocatalyst for the electroreduction of 
nitromethane, the catalytic activity is evaluated using Michaelis-Menten kinetics. The 
apparent Km and the turnover number kcat are derived from non-linear regression of 
Michaelis-Menten plot using Origin software. The reductive products of catalytic 
electroreduction of nitromethane are identified by a mass spectrometric method. We also 
identified a ferrous heme-nitrosomethane as the intermediate in the catalytic process 
using UV-Vis spectroscopy and electrochemical techniques. We show the 
 iv
electrochemical signature of a nitrosoalkane-heme complex that is possibly involved in 
the mechanism of activation of aliphatic nitro-compounds xenobiotics. A possible heme-
mediated electroreductive pathway is proposed. 
In this work, we also explored the comparative study of the electroreduction of 
nitromethane using myoglobin, hemin, and iNOSoxy as the electrocatalysts. We 
discussed the role of the protein shell in the activation process. We also studied four 
different aliphatic nitroalkanes as substrates to study their electro activation using hemin 
and iNOSoxy as electrocatalysts, and used a mass spectrometric method to identify the 
reduction products. By comparing the catalysis of each nitroalkane substrate and by 
varying experimental conditions such as scan rate of cyclic voltametry, substrate 
concentration, and pH, we discussed the effects caused by the physical and chemical 
properties of the substrates on their electrocatalytic reductions.  
 v
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GENERAL INTRODUCTION 
 
Due to their widespread use, the human body is frequently exposed to nitro-
compounds. Nitroalkanes are recognized as carcinogens1, 2, genotoxicant,2, 3 and are 
suspected as cardiovascular toxins and neurotoxins.4-6 The detailed mechanism of 
nitroalkane-induced carcinogenesis is still unclear. It is believed that nitro-compound 
activation may take place in the liver, catalyzed by xenobiotic enzymes under anaerobic 
conditions through catalytic electron transfer.7, 8 Research has shown that cytochrome 
P450 participates in the reductive metabolism of nitro-compounds.9 It also has been 
reported that 2-nitropropane reductive metabolite, N-isopropylhydroxylamine (IPHA), 
frequently causes DNA damage at thymine.2 The formation of 8-hydroxydeoxyguanosine 
(8-OHdG) induced by IPHA is speculated to be involved in oxidative stress-related 
carcinogenesis.10 To better comprehend the carcinogenesis of nitro-compounds, it is 
important to understand the fundamental reductive pathways catalyzed by heme-base 
proteins and enzymes.  
Chemicals (including drugs) involve two-phase reactions in the metabolism. Phase I 
reactions are nonsynthetic reactions, including reduction, oxidation, and hydrolysis. 
Phase II reactions are known as conjugation reactions, and usually involve the 
interactions of the metabolites from phase I. This process usually detoxicates the 
chemicals. These reactions are catalyzed by a family of enzymes called xenobiotic 
metabolizing Cytochrome P450s. The metabolizing process will result in toxication or 
detoxication, also called activation and deactivation. The mechanisms of cytochrome 
P450 catalysis and inhibition have been the subject of intense studies in recent years. 11-14 
Carcinogen and mutagen activations which occur in phase I are closely related to the 
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activity of Cytochrome P450s. Therefore, Cytochrome P450s became vital enzymes for 
the study of the mechanism of formation of carcinogenic metabolites. 
Traditional methods of enzyme activity study include assays on initial rate, progress 
curve and transient kinetics through varying techniques such as spectrophotometric 
methods, light scattering methods, fluorometric methods, chemiluminescent methods, 
calorimetric methods, chromatographic methods, and radiometric methods. These 
methods can resolve enzyme mechanisms in concentration and time domain by 
measuring concentration change of substrate or product versus time, but little information 
can be obtained on the mechanism of catalytic reaction at the molecular level. 
Most commonly used analytical techniques in recent investigations of P450 enzymes 
and their activation of xenobiotic compounds or their metabolites are HPLC, UV-Vis, 
Mass Spectrometry, and Electrochemical methods. Electrochemical methods show the 
advantages of being quantitative, sensitive and relatively uncomplicated. 
Since more than 30% of enzymes are oxidoreductases including P450 heme enzymes, 
their activities involve electron transfer coupled with substrate transformation at the 
catalytic site that can be monitored electrochemically. This dynamic voltammetric 
approach obtains not only the kinetic information of enzymatic reactivity, but also the 
electrochemical potential, which defines the oxidation states and the rate of catalytic 
reaction. 
The voltammetric electrochemical method on biomolecules such as proteins showed 
its potential first in the late 1970’s when the direct (unmediated) voltammetry of 
cytochromes was obtained at solid electrodes.15 This approach was enhanced when 
enzymes or other molecules of interest are attached or absorbed on the electrode surface. 
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The techniques of immobilization includes covalent attachment, self assembled 
monolayers (SAM), and bilayer thin film methods or layer-by-layer assembly. The 
commonly used materials used for these applications as solid electrodes are platinum, 
gold, silver, or even indium doped tin oxide transparent electrodes. 
In our study, we use mostly the lipid bilayer thin film method. The catalysts or 
enzymes under investigation are embedded in a biomembrane-like surfactant bilayer 
structure on the surface of pyrolytic graphite electrode. The electrochemical studies of the 
enzymatic activity are combined with other analytical chemical techniques, such as 
spectrophotometric methods and mass spectrometric methods, in effort to understand the 
underlying mechanism of enzymatic or heme-based catalytic nitroalkane electroreduction. 
 3
  
 
 
 
 
CHAPTER I 
CURRENT METHODS OF INVESTIGATING THE METABOLISMS OF 
NITROCOMPOUNDS 
 
1.1 Introduction 
 
Nitroalkanes are widely used as solvents, chemical intermediates or fuel in racing 
cars or rockets. Large amounts of nitroalkanes are released into the environment and 
result in environmental contamination. Chronic intake of these compounds may cause 
neuropathy,4 DNA damage,2, 3 and cancer.16, 17  
As other xenobiotics, the metabolism of nitroalkanes is catalyzed by a superfamily of 
enzymes called Cytochrome P450s (CYPs). Human CYPs are mostly membrane-
associated enzymes, located either in the endoplasmic reticulum or in the inner 
membrane of mitochondria of cells, and some CYPs exit in cytosol as well. CYPs are in 
charge of metabolizing thousands of exogenous and endogenous compounds. Most CYPs 
can metabolize multiple substrates, and many can catalyze multiple reactions, which 
enable them to catalyze the transformation and degradation a large variety of molecules. 
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Cytochromes are proteins that carry a heme protoporphyrin IX group as their 
prosthetic group, Figure 1.1. The heme group is a highly conjugated ring with an iron 
atom in the center. The oxidation states of iron readily interconverts between +2 and +3 
through electron transfer. It can perform as either an electron source or an electron sink. 
This characteristic makes it capable to catalyze either oxidations or reductions.  
Cytochromes P450 serve crucial functions in humans. The subfamily that act as 
xenobiotic-metabolizing enzymes is a prime target in pharmacology and drug 
development.18. The name P450 comes from its characteristic Soret peak at 450 nm of the 
reduced carbon monoxide-bound complex19, 20. P450 enzymes catalyze the activation of a 
variety of xenobiotics including almost all drugs and chemicals. For example, P450 
enzymes metabolize organic nitrates, 21, 22 lauric acid and ethanol. 23 Cytochrome P450 
belongs to a multi-gene family; so far more than 6,400 distinct Cytochrome P450 
sequences are known from all variants of life, including mammals, plants, and even 
bacteria. There are 57 genes and 59 pseudogenes recognized so far coded for different 
Cytochrome P450s in the human genome. 
 5
  
 
 
Figure 1.1 Crystal Structure of human cytochrome P450 46A1 
Image from PDB 2Q9G 
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There is a structural diversity among Cytochrome P450s. Nonetheless, they share 
many common features: 1) Cytochrome P450s have a heme group as the active site. 2) 
The iron in the heme is coordinated to a cysteine thiolate ligand at the proximal site. This 
cysteine and many other peptides in the enzyme are highly conserved over all known 
Cytochrome P450s. 3) The catalytic function of cytochrome P450 needs other partner 
proteins such as Cytochrome P450 reductase or ferredoxins to donate and shuttle 
reducing equivalents (electrons) to the heme Fe(III) center.  
The mechanisms of cytochrome P450 catalysis and inhibition have been the subject 
of intense studies in recent years. 11-14 Carcinogen and mutagen activations which occur 
in phase I are closely related to the activity of Cytochrome P450s. Therefore, 
Cytochrome P450s became vital enzymes for the study of the mechanism of formation of 
carcinogenic metabolites. 
The general mechanism of the cytochrome P450 aerobic catalytic cycle is well 
known (Scheme 1.1). 24 It involves heme activation (Fe3+ reduces to Fe2+), oxygen 
binding and activation, and then hydroxylation of the substrate. 
 7
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Scheme 1.1 Mechanism of Cytochrome P450 aerobic catalysis24 
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However, not all xenobiotics take the oxidative metabolic pathway. Some nitro-
compounds can be reductively activated by Cytochrome P450s.25 Nitroalkanes can either 
be reduced or oxidized by different enzymes. They could be oxidized by P450 enzymes 
under aerobic conditions initiated by electron transfer, and oxygen activation 7. They 
could also be reduced by Cytochrome P450s under anaerobic conditions through catalytic 
electron transfer. 7-9 The primary product of nitroalkane reduction is alkyl hydroxylamine 
26. Fitzpatrick’s group reported their work on a FAD-containing enzyme called 
nitroalkane oxidase from fungus, and stated that the oxidation products of nitroalkanes 
are aldehydes or ketones with nitrite and hydrogen peroxide as side products 27.  
Cytochrome P450s are responsible for the metabolism of almost all kinds of 
chemicals including drugs. The activation of drugs by P450s can either lead to non-toxic 
metabolites or cytotoxicants, genotoxicants, and carcinogens; hence, CYPs are key 
enzymes for studying the metabolism and potential toxicity of drugs. A number of 
investigations have been carried out to study the effects of nitro-compounds on animal 
models or human samples, and there are also reports of cases showing health problems 
caused by the exposure to these chemicals. The techniques that have been commonly 
used in the studies are the following including spectroscopic methods such as UV-Vis 
spectroscopy, infrared spectroscopy, high performance liquid chromatography (HPLC) 
coupled UV-Vis or mass spectroscopy (MS), biological techniques such as gel 
electrophoresis, comet assay (single cell electrophoresis), Ames mutagenicity test, and 
electrochemical methods which are primarily used in our study. 
UV-Vis spectroscopy has been commonly used to determine the concentration of 
protein samples, quantitatively measure the change of the reactive species, and monitor 
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the formation of new species. Because of its capability, this technique is constantly 
applied to the studies of cytochrome P450s catalyzed nitro-compound metabolism. 
H.G. Jonen used UV-Vis spectroscopic method to study the nitrofurantoin 
metabolism in rat liver under aerobic and anaerobic conditions.28, 29  His results showed 
that nitrofurantoin can be rapidly eliminated under anaerobic condition through a 
reductive metabolism. Under aerobic condition, the hepatic clearance of this chemical is 
slow. 4-hydroxylation of nitrofurantoin is catalyzed by 3-methylcholanthrene-inducible 
cytochrome P450. 
Mansuy’s group studied the interaction between hemoproteins including P450 
enzyme and nitroalkanes and their metabolites under reducing conditions, and found out 
that nitroalkanes and hemoproteins form stable ferrous heme nitrosoalkane complexes 
under reducing condition using UV-Vis spectroscopic methods30, 31. Also N-
hydroxylamines can react with Cytochrome P450 under oxidative condition to form the 
same type of complexes.32 
Christopher Kohl et al reported on the toxicity of the genotoxicant and 
hepacarcinogen, 2-nitropropane.33 The results showed that the nitro-aci tautomerism of 2-
nitropropane catalyzed by rodent or human liver cytosol might be the reason for its 
toxicity. The study of 1-nitropyrene activation catalyzed by Human Hepatoblastoma Cell 
Line was also reported by Kimberley J. Silvers et al. 34 Their HPLC results showed that 
only nitroreduction pathway of 1-nitropyrene by HepG2 could form the DNA adduct, N-
(2'-deoxyguanosin-8-yl)-l-aminopyrene (dG-CS-AP), and the cytochrome P450-mediated 
C-oxidative pathways are detoxification pathways. 
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In a recent study of the hepatoxicity of an anti-tumor prodrug 5-(Aziridin-1-yl)-2,4-
dinitrobenzamide (CB 1954), HPLC coupled to mass spectrometry showed that the major 
metabolite, 4-hydroxylamine was formed,35 a potent DNA cross-linking cytotoxin. 2-
hydroxylamine and 2-amine metabolites were also detected and both of them exhibited 
high cytotoxicity. Another study reported on the metabolism of a nitro-containing drug, 
N1-phenyl-3,5-dinitro-N4,N4-di-n-butylsulfanilamide (GB-II-150),  and showed that the 
drug underwent nitroreduction when administered orally. 36 
Comet assay is useful to study the genotoxicant by monitoring the DNA damage. An 
investigation of 2-nitroproapne-induced DNA damage using animal model by Xin-Sheng 
Deng et al37 utilized this method and found out that DNA damage happened in bone 
marrow cells thus indicated that 2-ntiropropane could be leukemogenic. 
Ames test was used in an investigation carried out by Peter P. Fu et al on the 
mutagenesis of nitrobenzo[a]pyrenes (NBaPs).38 The results indicate that isomeric NBaPs 
are activated to DNA adducts and mutagenic derivatives by nitroreduction, ring-
oxidation, or by a combination of these two pathways.  Another report using the same 
approach to study the mutagenicity of various nitrocompound was conducted by S. G. 
Salamanca-Pinzon et al.39 The results illustrated that the mutagenicity of the 
nitrocompound metabolites related to nitroreductase proficiency. All nitrocompound 
showed more mutagenic after metabolic activation by nitroreductase.  
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1.2 Electrochemical methods 
The metabolic mechanisms of chemicals catalyzed by cytochrome P450 (CYP) 
enzymes involve electron transfer. In biological systems, enzymes such as CYPs have to 
use electron donors such as NADPH or NADH to perform their enzymatic activity, and 
they are affected by electron transfer mediators such as flavin nucleotides. The advantage 
of direct electrochemical methods are that if enzymes such as CYP can be connected to a 
solid electrode surfaces by a bridge, and the active site of CYP, a heme group, can 
exchange electrons with the underlying electrode, there is no need to have the electron 
donors or mediators in the system. We can thus study the enzymatic reactions by 
providing electrons directly from the electrode. 
The current response on the electrode is directly related to the rate of the reaction and 
the amount substrate being processed. Hence it is a quantitative method. When using 
dynamic voltammetric technique, electrode potential can reflect thermodynamic 
information of the enzyme as well as enzymatic kinetics. High sensitivity is the nature of 
electrochemical method; therefore the amount of enzyme sample can be very small. 
There are numbers of electrochemical techniques available. Because of the 
advantages, electrochemical techniques of studing metalloeproteins especailly CYP heme 
enzymes have drawn more and more attention in the last couple of decads. In the 
appendix we describe the common methods that we used throughout this work.  
Cyclic voltammetry (CV) is probably the most versatile electrochemical technique for 
the mechanistic study of redox active systems. Direct electrochemistry of P450 enzyme 
was reported in the literature that have protein shows typically a reversible FeIII/FeII 
redox couple of the prosthetic heme group.40-43  
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1.3 Protein immobilization methods 
Before the development of biomolecule immobilization methodology, the 
electrochemical studies of proteins or enzymes were carried out in solution and the signal 
obtained directly at the working electrode was facilitated by small mediators. This 
approach not only requires large amount of enzyme or proteins, but the signal is also very 
weak. The protein immobilization method confines the protein on the surface of working 
electrodes instead of in solution. This approach not only saves lot of protein sample, but 
also enhanced the electrochemical current signal. Since direct (non-mediated) electron 
transfer through metalloprotein was achieved, the electrochemical study of 
metalloproteins began to attract the interest of investigators and became more and more 
popular. 
The techniques of immobilizing native proteins on working electrodes are critical in 
the research and various methods of immobilization are developed for different 
applications. 
1.3.1 Adsorption 
Proteins such as Cytochrome P450s can be directly deposited on the metal or 
graphite electrode. Purified CYP solution can be spread on a basal plane pyrolytic 
graphite surface, 44 and the film is formed simply by evaporating water naturely. Protein 
or peptide modification can also be done electrochemically by cycling a gold electrode at 
reducing potentials in the peptide solution as described by J. Kazlauskaite et al.45 
Besides direct adsorption, co-adsorbates such as polyamines,46 neomycin47-49, and 
polymyxin50-55 have been used for protein immobilization. These polyamines can bind to 
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negatively charged parts of protein under neutral pH and form salt bridges between 
protein and electrode surface.  
Other adsorption methods involves nano-particles56 such as titanate nanotubes,57 
carbon nanotubes,58-70, gold nanoparticles,71, 72 and silver nanoparticles.73 
1.3.2 Hydrogel or clay entrapment 
The electron transfer between the electrode and protein is usually low for a protein-
modified electrode by absorption. Therefore application of substances that facilitates 
electron transfer may enhance the intensity of the signal and the stability of the protein 
film. There are a numbers of choices of film-forming materials such as colloid size clay,74, 
75 hexagonal mesoporous silica (HMS),76 polyacrylamide (PAM) hydrogel films,77, 78 and 
carboxymethyl cellulose films,79 to cite a few. 
1.3.3 Lipid bilayer thin films 
Some amphiphilic compounds (surfactants) such as didodecyl dimethyl ammonium 
bromide (DDAB) can form a water-insoluble bilayered film structure that resembles bio-
membranes on solid electrode surfaces, Figure 1.2. Both hydrophilic and hydrophobic 
proteins or other molecules can be embedded into these surfactant thin films. This 
method of protein immobilization promotes the electron transfer between the protein and 
the electrode. Research had shown that the film is fairly stable in aqueous environment 
and the proteins could maintain their native structure in the lipid thin film.80-82 This 
method is suitable for applications such as biosensors and bioreactors, and also widely 
used in the electrochemical investigations of catalytic mechanisms of enzymes and other 
proteins.80, 81, 83-86 
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Figure 1.2 Protein immobilized in bio-membrane like lipid film on pyrolytic graphite 
(PG) electrode. (a) Lipid molecule (b) Protein moleclue (c) Pyrolytic graphite (PG) 
electrode 
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1.3.4 Covalent attachment 
Biomolecules such as proteins can form covalent bonds with specific chemical 
groups on the electrode surface. This usually involves a step called functionalization of 
the electrode surface. The desired chemical group(s) is covalently attached to the 
electrode surface usually through defined chemical reactions.  
Functionalized alkyl thiols can be spontaneously adsorbed onto Au, Pt, and Ag 
surface to generate self-assembled monolayers (SAM) with the functional groups 
pointing away from the electrode so that it can engage the protein molecules, Figure 1.3.  
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Figure 1.3 Immobilization via covalent attachment of proteins  
 
 17
1.3.5 Layer-by-layer polyion protein adsorption 
Electrostatic coupling can be used to deposit charged compounds onto a charged 
electrode surface. Layer-by-layer (LBL) deposition is a technique of thin film fabrication. 
The method consists of applying oppositely charged polyions respectively with washing 
step in between. Just like the name indicates, the resulting film has alternative layers of 
negatively charged and positively charged polyions. The number of layer and the 
thickness of the film can be well controlled, Figure 1.4. Proteins can bear different 
surface charge at different pHs. Therefore this method is used for protein immobilization. 
Some multi-charged matrices such as poly(diallyl dimethyl ammonium chloride) (PDDA) 
can be used to couple with negatively charged polyions or proteins to form protein-
containing LBL films. 
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Figure 1.4 Layer-by-layer polyion adsorption 
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1.4 The approach we took in our study 
The electrochemical technique using surface confined metalloprotein especially 
enzymes, may not only apply to substrate-specific biosensors and bioreactors, but can 
also be used commonly to study enzymatic activity of metalloenzymes. Since the 
majority of cytochrome P450 enzymes are located in hydrophobic environments such as 
the reticulum of cells or cell membranes, the study of such type of enzymes needs to 
mimic the physiological environments. In this work, we select well-known lipid thin film 
immobilization methods to retain our enzymes on the basal plane pyrolytic graphite 
working electrode surface. The lipid bilayer structure provides a biomembrane-like 
environment in which the protein molecule is embedded. We use electrochemical 
techniques as the major tools to characterize the redox activity of the heme group as well 
as electro activation of nitroalkane substrates. 
In addition to electrochemistry, UV-Vis spectroscopy is routinely used to monitor the 
concentration and integrity of hemoproteins. It is also employed to characterize possible 
reaction intermediates of heme-mediated catalytic nitroalkane electroreduction.  
    Final products of electroreductions mediated by immobilized hemoproteins, as well as 
their distribution are needed to shed light on the complex activation pathways, and to 
identify the plausible mechanism. To analyze the final electroreduction products, we used 
bulk electrolysis (i.e. exhaustive reduction at the potential of the catalytic wave on the 
heme or (protein)-modified electrode) and analyze the products at different times using 
mass spectrometry (MS). The setup that allows for bulk electrolysis and analysis of 
products been developed in the past87-90. The system is adapted to this work. 
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CHAPTER II 
STUDY OF MYOGLOBIN-MEDIATED NITROMETHANE ELECTRO-
REDUCTION AND THE CATALYTIC REACTION MECHANISM 
 
2.1 Introduction 
 
Nitromethane is the simplest aliphatic nitroalkane. It is recognized as a carcinogen, 
and is suspected to be a cardiovascular toxin and neurotoxin.1, 2 Nitromethane 
transformation in human body is believed to be catalyzed by P450-type xenobiotic 
enzymes under anaerobic conditions through catalytic electron transfer.3, 4 
Nitromethane is electroactive and can be electroreduced to methyl hydroxylamine at 
electrode surface. The process can be simplified as in Equation 1. This electrochemical 
reaction consists of 4 electrons and 4 protons uptake in addition to a break of N-O bond 
and involves a complex mechanism.5 
OHNHOHCHHNOCH e 23
4
23 4 +⎯→⎯+ −+      (1) 
The active sites of cytochrome P450s (CYPs) are heme groups. Chemicals and drugs 
transformations are catalyzed by the heme groups in P450s. Electrons in CYP-catalyzed 
chemical metabolism come from cytochrome P450 reductases involves a subfamily of 
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flavoproteins designed to provide electrons to CYPs. Electrochemical study has the 
advantage that proteins can get electrons directly from the electrode, hence the electron 
provider CPR and the cofactor NADPH are not required. 
Although there are large varieties of CYPs, the active site of the enzyme is highly 
conservative. The iron in the heme group is tethered through a thiol ligand from a 
cysteine residue, this cysteine and some other amino acid residues around it are also 
highly conserved. We chose a simple hemoprotein (myoglobin) to start our study on the 
interaction between nitroalkane with heme group. Myoglobin is easily available and had 
been electrochemically studied extensively.6-15 Previously published work in this lab has 
shown that myoglobin is an efficient catalyst in electroreduction of nitromethane.16 
Myoglobin is a primary oxygen-carrying protein in muscle tissues, Figure 2.1. The 
crystal structure of myoglobin17 showed that the NЄ atom of the proximal histidine 
residue (His93 in horse heart myoglobin) acts as the fifth coordination of the iron atom of 
the porphyrin ring, and leave only the distal (or trans-axial) side of the porphyrin plane 
accessible to ligands such as oxygen. There is another histidine residue (His64 in horse 
heart myoglobin) at the distal side which helps stabilize the binding of the ligand through 
hydrogen bonding. 
Some electrochemical studies of surface confined myoglobin focused on the 
electrochemical characteristics of myoglobin,8, 15 and others also focused on the 
myoglobin catalyzed electroreductions.6, 11, 18, 19 In this work, we study the myoglobin-
mediated nitromethane reduction. 
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Figure 2.1 Structure of nitromethane modified horse heart myoglobin 
Image from: PDB 2NSR 
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Traditionally potentiometric titration 20-23 was the main approach to investigate the 
thermodynamics and sometimes the mechanisms of electron transfer of in enzymatic 
processes. This method is not suitable for studying kinetics of reactions. Another 
drawback is that this approach requires relatively large quantity of enzyme samples. 
More recently, direct electrochemistry 24-26 of metalloproteins became more popular 
because of the speed and wealth of inforamtion that it provides. This approach is much 
more versatile and powerful; if not only gives access to thermodynamic data, but it also 
provides information  on the kinetics of electron transfer. 
Direct electrochemical study of metalloproteins requires direct electron transfer 
between protein and electrode surface. The surfactant thin film methodology 27, 28 was 
developed to study a variety of metalloproteins. The film-forming surfactant employed in 
our work and widely used in other investigations 16, 28-31 is didodecyl dimethyl 
ammonium bromide (DDAB).  
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2.2 Experimental Design 
2.2.1 Materials 
Horse heart myoglobin is purchased from Sigma. Myoglobin is purified as in 
reference32 before use. Didodecyldimethyl-ammonium bromide (DDAB) and 
nitromethane are from Acros Organics.  
Nitrogen gas is purchased from PRAXAIR. Deionized water is obtained from a 
Barnstead Nanopure system with a resistivity greater than 18 MΩ·cm. Pyrolytic graphite 
(Advanced Ceramics) is the material for working electrodes. Homemade working 
electrodes are prepared as in reference,16 and the fabrication process is described below. 
2.2.2 Fabrication of the pyrolytic graphite (PG) working electrode 
A pyrolytic graphite block is cut perpendicularly to the basal plane using a diamond 
core drill bit to make a cylinder of the graphite with diameter of ~3.2mm. The cylinder 
lock is then cut into small cylinders with a scalpel blade along the basal plane to make 
each cylinder about 3 mm tall. A piece of copper wire (precut 15 cm) is connected to one 
end of the graphite cylinder using conductive epoxy, and allowed to dry. The graphite 
cylinder is then inserted in a glass tubing (ID=4mm) and set in place with non-conductive 
epoxy and allowed to dry, figure in appendix B. The non-conductive epoxy is also used 
to seal the gaps between graphite and glass. The finished electrode is then polished and 
cleaned.  
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2.2.3 Electrode modification 
 Myoglobin (Mb) is immobilized in DDAB surfactant film on a basal-plane pyrolytic 
graphite (PG) disc electrode28, 33 (surface area is ~0.08 cm2), (Mb/DDAB/PG). Before 
film casting, the PG electrode is polished using 400-grit sandpaper followed by 0.3μm 
alumina slurry. The polished electrode is then rinsed and sonicated in distilled water.  
Mb/DDAB surfactant film is prepared by casting 10μl of 10mM DDAB in H2O followed 
by 10μl 0.4mM myoglobin solution. The modified PG electrode is then allowed to dry in 
air for more than 12 hours. DDAB emulsion is prepared by dissolving DDAB powder in 
deionized water. The emulsion is then sonicated for at least 2 hours or until the solution 
becomes clear. Myoglobin buffer solution is prepared by dissolving myoglobin in 0.1M 
acetate buffer (pH 5.5) or in other suitable buffers. 
2.2.4 Procedures and Apparatus 
2.2.4.1 Electrochemical Measurement 
Cyclic voltammetry (CV) is an excellent tool to study the heme iron redox activity 
through electron transfer. Another electrochemical technique that we use is rotating disk 
voltammetry (RDV). This hydrodynamic electrochemical method can provide steady 
state current needed to measure true values of the catalytic current. Therefore, it is 
routinely used in electrochemical study of enzyme catalysis.34-36 
All electrochemical experiments are conducted using a three-electrode system (Figure 
2.2) on a BAS 100B electrochemical workstation or CH Instrument. Ag/AgCl (3M KCl) 
is used as reference electrode and all potentials are reported versus this reference. A 
platinum wire is employed as the auxiliary electrode. Modified PG electrodes are used as 
working electrodes of course.  
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Figure 2.2 Electrochemical setup 
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All electrochemical experiments are performed in 0.1M acetate buffer (pH 5.5) 
containing 0.1M sodium bromide. The solution in the cell is purged with purified 
nitrogen for at least 15 min prior to experiments to remove oxygen from the solution. A 
nitrogen blanket is maintained to prevent contamination with oxygen from air.  
2.2.4.2 Bulk Electrolysis 
Bulk electrolysis is performed using a modified large area PG electrode as working 
electrodes. The electrode is poised at the potential where the electro catalysis occurs. 
Constant stirring is maintained to ensure mass transfer during electrolysis. The amount of 
substrate converted during the process is calculated using initial and final concentrations. 
2.2.4.3 Mass Spectrometry 
A sample of the solution after bulk electrolysis is infused into a Micromass Quattro II 
electro-spray triple quadrupole mass spectrometer (ESI-MS) to identify and quantify the 
products of the catalytic nitromethane electroreduction. The calibrations of the possible 
products are conducted using triethylamine as an internal standard. 
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2.3 Results and Discussion 
2.3.1 Electrochemistry of Mb/DDAB/PG  
A cyclic voltammogram of Mb/DDAB/PG in pH5.5 acetate buffer, Figure 2.3, shows 
a pair of well-defined reversible redox couples; the first couple, R1/O1 (Equation 2), is 
assigned to FeIII/FeII with a formal potential –0.180V vs. Ag/AgCl. The R2/O2 couple, 
(Equation 3) with formal potential –1.052V vs. Ag/AgCl is tentatively assigned to 
FeII/FeI.16, 29, 32 
       (2) −−+−− ⎯→⎯⎯⎯←− IIIII FeMbeFeMb RO
1
1
11
−−+−− ⎯→⎯⎯⎯←− III FeMbeFeMb RO
2
2
11       (3) 
As has been shown in a number of reports the heterogeneous electron transfer is 
greatly enhanced in the surfactant film. In fact, as shown in Figure 2.4, when peak 
splitting ΔEp for the FeIII/FeII is plotted as a function of scan rate, the ΔEp stays 
unchanged in the range of scan rates from 0.001V/s to 1V/s, and then increases as 
expected at higher scan rates (i.e. shorter time frame) where electron transfer is 
kinetically challenged. Simulation of this behavior provides an estimate of the electron 
transfer rate. We find a ks of 0.01 cm/s indicating a fast electron transfer for this large 
protein. 
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Figure 2.3 Cyclic voltammogram of Mb/DDAB/PG  
in pH5.5 acetate buffer at 0.15 V/s. 
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Figure 2.4 Plot of ΔEp as a function of scan rate using  
Mb/DDAB/PG electrode in pH 5.5 buffer 
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2.3.2 Electrocatalytic reduction of nitromethane 
 The cyclic voltammogram as described earlier dramatically changes after introducing 
nitromethane. Figure 2.5a shows the typical voltammogram of Mb/DDAB/PG electrode 
in pH5.5 buffer in absence of nitromethane. There are 2 pairs of redox couples assigned 
to FeIII/FeII (formal potential at -0.18V vs. Ag/AgCl) and FeII/FeI (formal potential at -
1.06V vs. Ag/AgCl), respectively. Upon addition of nitromethane, a new peak, Rc, 
appears at -1.0V vs. Ag/AgCl in parallel with the disappearance of the FeII/FeI (Figure 
2.5b). A control experiment (Figure 2.5c) is conducted with a DDAB/PG electrode 
without embedded Mb as working electrode under the same conditions. The Rc peak 
current is significantly higher than that of the control experiment and the Rc peak 
potential is more positive compared to the control voltammogram (-1.16V in Figure 2.5c). 
The new Rc peak appearing at potentials more positive than FeII/FeI redox couple and the 
disappearance of the later are both indicative of an electro catalytic process mediated by 
myoglobin. 
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Figure 2.5 Cyclic voltammograms of DDAB/PG and Mb/DDAB/PG electrode in pH 5.5 
acetate buffer solution at the scan rate 0.15V/s. (a) Mb/DDAB/PG without nitromethane, 
(b) Mb/DDAB/PG with 0.4 mM nitromethane, (c) DDAB/PG with 0.4 mM nitromethane. 
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Literatures showed that myoglobin maintains its native structure in a certain pH range 
when immobilized in the surfactant films such as DDAB.15, 32, 37 However, other 
investigations claimed different results. Some reports state that heme is released from 
myoglobin in DDAB surfactant film,38, 39 and the electrochemical signals of myoglobin 
arise actually from the free heme.  
 In our hands and under our conditions, myoglobin maintains a native-like structure 
and the redox activity observed comes from its intact form. In fact, cyclic voltammetry 
performed with chemically denatured (SDS treated) myoglobin on the electrode surface 
gives a different behavior. The voltammogram (Figure 2.6a) shows that the previously 
well defined 2 redox couples (Figure 2.5a) has drastically changed. Also in support of our 
results, the catalytic function of the denatured protein is lost in the presence of 
nitromethane substrate. The reductive wave at –1.1V (Figure 2.6b) is the direct 
electroreduction of nitromethane. Our results are in support of the fact that myoglobin 
retains its native-like structure in our surfactant films. 
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Figure 2.6 Cyclic voltammograms of SDS denatured* myoglobin electrode in pH5.5 
buffer. (a) 0 mM nitromethane (b) 0.4 mM nitromethane. 
*Myoglobin solution was treated with 1% SDS solution prior to electrode modification. 
10μl of the SDS treated myoglobin suspension after vortexing was used along with 10μl 
DDAB solution to modify a PG electrode (procedure refer to section 2.2.3). 
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2.3.3 Effect of nitromethane concentration 
The catalytic reduction current obtained from cyclic voltammetry can provide 
quantitative information of on turnover and other kinetic aspects in the thin film. Figure 
2.7A shows myoglobin-mediated nitromethane reduction catalytic currents at different 
substrate concentrations. Catalytic current Icat as a function of substrate concentration [S] 
is shown in Figure 2.7B. The plot exhibits linear relationship between Icat and [S] when 
[S] is smaller than 0.6 mM. The plot starts to curve down greater concentrations, which is 
typical for enzyme saturation kinetics. The plot can be fit to Michaelis-Menten kinetics, 
Equation 4.  
][
][max
SK
SVV
m +
×=  (Michaelis-Menten Equation)    (4) 
Equation 5 shows the scheme of enzyme-catalyzed substrate transformation. E 
symbolizes the enzyme, S the substrate, ES is enzyme-substrate complex, and P is 
product. 
E + S        (5) PEES k +⎯→⎯ 2k1k-1
1
21
k
kkKm += −         (6) 
Km, as defined in Equation 6, is an indication of the constant of the formation of 
enzyme-substrate complex. It also reflects the catalytic constant k2 or kcat, the turnover 
number.  
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Figure 2.7A Voltammograms of Mb/DDAB/PG electrode in pH 5.5 acetate buffer 
solution at a scan rate of 0.15V/s in the presence of (a) 0.3 mM, (b) 0.8 mM, (c) 1.3 mM, 
(d) 2.0 mM nitromethane.  
Figure 2.7B Catalytic current of nitromethane catalytic reduction by Mb/DDAB/PG as a 
function of nitromethane concentration. 
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 To quantify Km and kcat electrochemically, we need to use the electrochemical form 
of Michaelis-Menten equation can be expressed by Equation 7 40 under steady-state 
conditions: 
][
][
SK
SknFAI
m
cat
cat +
×Γ=         (7) 
where Г is the surface concentration of catalyst, F is Faraday’s constant, A is the surface 
area of the electrode, [S] is substrate concentration, Km and kcat are the usual Michaelis-
Menten parameters.  
To calculate the total amount of active catalyst on the electrode surface we typically 
use an electrochemical technique based on current integration (i.e. charge measurement) 
of voltammograms taken at very slow scans.15 The integration of the reductive peak of 
FeIII-heme/ FeII-heme from a linear potential scan at 5mV/s gives the amount of active 
heme proteins in the surfactant films, Figure 2.8. The average value for Mb/DDAB is 
around 21.2 picomoles; accordingly the surface concentration is 2.65 × 10-10 mole/cm2, 
which is in the same range of the value reported in the literature.15 
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Figure 2.8 Typical linear voltammogram of Mb/DDAB/PG electrode in pH5.5 
acetate buffer at scan rate 5mV/s; Integrated area under the voltammogram is shown as 
filled. 
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Figure 2.9 shows the plots of normalized catalytic current, Icat / , versus 
substrate concentration [S] plot of Mb/DDAB-catalyzed reaction. Non-linear fitting the 
plots (Figure 2.9) using Equation 7 gives the regression parameters k
ΓnFA
cat and Km. The 
parameters are shown in Table 2.1. 
Table 2.1 Regression parameters from Figure 2.9 
 
Km
(mM) 
kcat
(s-1) 
kcat / Km
(s-1 · mM-1) 
Myoglobin 1.9 ± 0.2 20.9 ± 1.8 11.2 ± 2.1 
 
The parameter Vmax / Km (or kcat / Km) is the rate of catalysis at the substrate 
concentration [s] close to 0, equation 7, and is usually used to define the catalytic ability 
or efficiency of an enzyme.  
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Figure 2.9 Catalytic current of Mb/DDAB/PG normalized by catalyst surface 
concentration as a function of nitromethane concentration. 
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 2.3.4 Effect of scan rate 
One can study the electron transfer and mass transfer kinetics using diffusion-
controlled technique such as cyclic voltammetry. Increasing scan rate shortens the 
timescale within which the catalytic reaction is monitored. As expected the catalytic 
efficiency, defined by the ratio Icat / I0 29 is larger at small scan rate and gradually drops as 
the scan rate increase, Figure 2.10. This behavior is typical of electrocatalytic process and 
can be used to extract kinetic information. 
The peak potential of the catalytic wave is plotted as a function of scan rate, Figure 
2.11. The figure shows that the catalytic peak shifts negatively with increasing scan rate. 
Since the catalysis is triggered within the time scale defined by the scan rate, this shift is 
an indication that more energy is required for the catalysis to occur in a higher scan rate. 
A chemical and/or an electrochemical step(s) in the catalytic reaction could be rate 
determine during the catalysis. 
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Figure 2.10 Catalytic efficiency as a function of scan rate. 
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Figure 2.11 Catalytic peak potential as a function of scan rate 
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2.3.5 Effect of pH 
 The electroreduction of nitromethane involves protons uptake.5 The catalytic 
reduction is also a proton-coupled process, which we will discuss later in the mechanistic 
study. Therefore, the availability of protons will affect the catalytic process. We conduct 
cyclic voltammetry under a series of pH values to monitor the effect of proton availability 
on the myoglobin-mediated reduction of nitromethane. 
 Figure 2.12A shows that the catalytic current drops with increasing pH. Figure 2.12B 
shows that the catalytic current changes slowly from pH 5.5 to pH 9, and then sharply 
from pH 9 to pH 11. Studies have shown that nitromethane is polar and exists in different 
forms under different pHs.41 The aci-nitro tautomerism of nitroalkane shows the 
equilibria of nitronic acid, R1R2C=NO2H (aci form), nitroalkane, and the nitronate anion 
R1R2C=NO2- in neutral or basic medium, Equation 8.41  
 
R1R2C=NO2H       R1R2C=NO2- + H+        R1R2CH-NO2 (8) 
k2 
k-2 
k-1 
k1 
 
 Nitromethane stays in nitro-from under acidic pH and transforms to aci-form in basic 
media. The dissociation constant of the aci form of nitromethane to the nitronate anion.42 
It is known that the formation of the anion of the aci form of nitromethane in alkaline 
solution prevents the reduction.42 This can partially explain the sharp decrease of 
catalysis when pH is greater than 9, Figure 2.12B.  
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Figure 2.12A Cyclic Voltammograms of Mb/DDAB electrode in the presence of 0.1mM 
of nitromethane in different pH solution. 
Figure 2.12B Catalytic current, Icat, as a function of pH. 
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It is known that water is the heme ligand in acidic environments and hydroxide 
becomes the ligand under basic conditions.27 Thus the fast drop of catalysis is not only 
caused by the availability of proton, but also the competitively binding of nitromethane 
with hydroxide ion to the heme iron.27 At pH 11, the catalytic current is not observed, 
indicating that the proton concentration cannot support the catalysis. 
The catalytic peak potential is affected by the pH, Figure 2.13. The shift of reduction 
potential with pH may reflect the change of ligand binding properties to the heme as well 
as the change of proton availability that drives the catalysis. There is also a clear turning 
point at pH 9.5 in Figure 2.13, which shows a change of the slope of pH dependency. The 
sharp decrease of catalytic peak potentials can be partially due to the intrinsic 
dissociation of nitronic acid to nitronate anion, which is difficult to reduce. 
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Figure 2.13 Potential of the catalytic reduction of 0.1 mM nitromethane on 
Mb/DDAB/PG electrode as a function of pH.  
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2.3.6 Number electrons per nitromethane molecule in myoglobin-mediated catalysis 
We used the bulk electrolysis method to measure how many electrons pass through 
Mb/DDAB/PG and how much nitromethane is consumed. Bulk electrolysis is performed 
at the level of the catalytic peak at -1.0 V vs. Ag/AgCl under constant stirring. A large 
surface PG electrode modified with Mb/DDAB is used as a working electrode. The 
starting concentration of nitromethane is 1.96 mM in 5 mL of solution, and the 
concentration of nitromethane after the process is measured by an electrochemical 
calibration method. The consumption of nitromethane is then derived, and the total 
number of nitromethane molecules consumed can be calculated. The total charge passed 
during the electrolysis is recorded by the electrochemical station. The electrons per 
nitromethane molecule can therefore be acquired. 
 The stoichiometric study derived that the ratio of total charges to the reduced 
molecules is close to 4:1, implying 4 electrons per nitromethane molecule consumed, and 
implies that nitromethane electroreduction yields mainly methyl hydroxylamine. Table 
2.2 shows the results of the number of electrons per molecule after bulk electrolysis for 
various trials.  
 
Table 2.2 Calculation of number of electron per nitromethane molecule  
 Total electrons 
passed 
Total nitromethane 
molecules reduced 
Electrons per 
molecule 
Average 
(mean ± SD) 
Trial 1 7.20 × 1018 1.54 × 1018 4.68 
Trial 2 7.33 × 1018 1.65 × 1018 4.44 
Trial 3 7.62 × 1018 1.80 × 1018 4.23 
4.45 ± 0.23 
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2.3.7 The products of catalytic reduction of nitromethane 
 In order to identify the products of the catalytic reduction, which is critical for the 
understanding of the reaction mechanism, we used a mass spectrometric method. The 
mass spectrometric technique we used to analyze the products of electrolysis of 
nitromethane electroreduction is semi-quantitative. Calibration curves (Figure 2.14) of 
the possible products are prepared using authentic compounds with triethylamine as the 
internal standard. The mass spectrometry analysis of the solution after bulk electrolysis 
shows that methyl hydroxylamine is the dominant product; the other possible reductive 
product methylamine was not detectable by the MS technique used (the detection limit is 
below 1 μM for this compound, Figure 2.14b). 
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 Figure 2.14 Calibration curve of methyl hydroxylamine (a) and  
methylamine (b) using QQQ-ESI mass spectrometer 
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2.3.8 Characterization of the intermediate of the catalytic reaction 
2.3.8.1 UV-vis spectroscopy 
We resorted to UV-vis spectroscopy to investigate the reaction between nitromethane 
and heme group and characterize possible intermediates complexes during the catalytic 
reduction of nitromethane. Mb-FeIII (Soret at 409nm, data not shown) is reduced to Mb-
FeII (Soret at 434nm, Figure 2.15) by adding excess amount of sodium hydrosulfite. The 
addition of nitromethane causes an absorption decrease at 434nm with concurrent 
absorption increase at 424nm giving an isosbestic point at around 430nm. The species 
with 424nm absorption is identical to that of ferrous myoglobin-nitrosomethane complex 
characterized in solution.43-45  
The heme(FeII)-nitrosomethane complex was studied by Mansuy’s group in their 
investigation of the reaction of aliphatic nitro compounds with myoglobin and 
hemoglobin under reducing conditions.46 Other reports43, 47 also stated that ferrous 
hemoproteins bind to nitrosoalkanes to form stable complexes that were characterized by 
UV-vis spectroscopy. 
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Figure 2.15 Evolution of the absorption spectra of reduced 10μM of Mb solution after 
addition of 25 mM nitromethane. Spectra were taken every 10s. 
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Nitromethane itself bind neither to Heme(FeIII) and nor to Heme(FeII).45 Consistent 
with these results, UV-vis experiments show no reaction between nitromethane and 
Heme(FeIII) (Figure 2.16A) or Heme(FeII) (Figure 2.16B).  
To examine if the myoglobin ferrous nitrosomethane complex forms during our 
heme-mediated electroreduction process, we poised a DDAB/PG electrode at –0.8 V in 
pH5.5 acetate buffer in the presence of nitromethane and Mb(FeII). The direct 
electroreduction of nitromethane at PG electrode will transform nitromethane to 
potentially nitrosomethane under these conditions; the latter should bind to Mb(FeII) to 
form the complex if any. UV-vis spectrum is taken before the catalysis and every 2 
minutes during the electrolysis. A complex with UV-vis features similar to those assigned 
by Mb-nitrosomethane forms during our reduction process triggered electrochemically.  
The results confirm that the myoglobin ferrous nitrosomethane complex is formed after 
the electrolysis, Figure 2.17. 
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Figure 2.16A UV-vis spectra of myoglobin in pH 5.5 buffer. (a) 0 mM of nitromethane, 
(b) 2 mM of nitromethane. 
Figure 2.16B UV-vis spectra of reduced myoglobin in pH 5.5 buffer. (a) 0 mM of 
nitromethane, (b) 2 mM of nitromethane. 
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Figure 2.17 UV-vis spectra of Mb(FeII) with nitromethane in pH 5.5 buffer solution. (a) 
Mb(FeII) + nitromethane before electrolysis, (b) after 2 minutes of electrolysis, (c) after 4 
minutes of electrolysis, (d) after 6 minutes of electrolysis, and (e) after 15 minutes of 
electrolysis. 
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2.3.8.2 Electrochemical signature of the heme ferrous nitrosomethane complex 
Since the ferrous nitrosomethane complex of myoglobin forms under our 
experimental conditions, we asked whether we could characterize it electrochemically. 
Under anaerobic condition, we preformed the nitrosomethane-heme(FeII) by reacting 
myoglobin solution with nitromethane in the presence of excess amount of dithionite. 
The reaction product was then used to modify our PG electrode under N2. The 
modification procedure refers to section 2.2.3. We performed cyclic voltammetry in pH 6 
buffer in the range of –0.8 to –1.1 V at a scan rate of 0.8 V/s. The myoglobin and 
nitrosomethane is expected to separate if Mb-nitrosomethane complex is oxidized.16 
Hence, all our experiments are performed under N2, and potential scan starts at –0.8 V to 
avoid the chemical or electrochemical oxidation of the Mb-nitrosomethane complex. Fast 
scan prevents the electroreduction from completion, which will cause dissociation of the 
complex and irreversibility. We were able to observe a reversible redox couple at the 
potential of –0.924 V (Figure 2.18) for this complex inside a narrow electrochemical 
window.  The possible reaction of this reversible electrochemical reaction is showed in 
Equation 9.  
+e-H3C N
Hm(FeII)
O
H3C N
Hm(FeII)
O
     (9) 
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Figure 2.18 Baseline-subtracted cyclic voltammogram of Mb(FeII)-
nitrosomethane/DDAB/PG electrode in pH6 buffer solution at a scan rate of 0.8 V/s.
 70
2.3.9 Mechanistic insights on the heme-mediated catalytic electroreduction of 
nitromethane  
According to the fact that neither ferric myoglobin nor ferrous myoglobin can bind 
nitromethane, and the myoglobin as the catalyst in the process needs to interact with 
substrate, the nitromethane substrate should change its state before the catalysis can 
happen. It is known that the first step of direct electroreduction of nitromethane forms 
nitrosomethane, which is the substrate for Mb(FeII) to form the myoglobin-
nitrosomethane complex as we discussed before. Another evidence is that the myoglobin-
mediated electroreduction peak starts at -0.75 V as shown in Figure 2.5, and the direct 
reduction peak of nitromethane on a DDAB only electrode starts also at -0.75 V vs. 
Ag/AgCl, Figure 2.19. It is an indication that the catalytic process is also triggered by the 
direct electroreduction of nitromethane. The following step will be the formation of 
Mb(FeII)-nitrosomethane intermediate. The electroreduction of the intermediate will be 
the next step. Based on the voltammetric behavior observed, the proposed catalytic 
reduction pathway is as follow: 
(a) heme reduction:  
Heme(FeIII) + e-  ?   Heme(FeII)     (10) 
(b) Heme-mediated nitromethane electroreduction: 
CH3NO2 + 2 e- + 2 H+    CH3N=O + H2O    (11) 
k1
k-1
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Figure 2.19 Cyclic voltammograms of DDAB/PG electrode in pH 5.5 acetate buffer 
solution at the scan rate 0.15V/s. (a) 0 mM nitromethane (b) 0.2 mM of nitromethane 
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 H3C    N 
O 
Heme(FeII) 
kS1CH3N=O + Heme(FeII)  (12) 
 
 
   + 2 e- + 2 H+           CH3NHOH + Heme(FeII)        (13) 
 
 
 H
 
In step (a), Heme-Fe(III) gains electrons and reduces to Heme-Fe(II), Equation 10. 
Step (b) shows the catalytic reduction of nitromethane using Heme-Fe(II) as a catalyst. 
During the negative potential scan of the cyclic voltammetry, nitromethane gains 2 
electrons from the electrode coupled with 2 protons and forms an unstable 
nitrosomethane CH3N=O, Equation 11.  
Nitrosomethane binds to typical hemoproteins irreversibly.43 The lone pair electrons 
on the nitrogen of the nitrosomethane readily coordinate the ferrous heme to from a stable 
ferrous-nitrosomethane complex, Equation 12. It is this intermediate that was 
characterized spectroscopically and electrochemically in this work. A further 2-electron 
process coupled to two protons reduces this intermediate to regenerates the catalyst along 
with the reduced product, Equation 13. A dissociation step gives out the final product,  
methyl hydroxylamine, with the release of the catalyst at the FeII state, Equation 14. 
3C    N 
OH 
Heme(FeII) 
H 
k2
Heme(FeII) + CH3NHOH   (14)
H    3C N 
O 
kS2
Heme(FeII) 
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2.3.10 Heterogeneous and homogeneous reaction rates 
The proposed heme-mediated nitromethane electroreduction pathway involves 
chemical and electrochemical reactions; the determination of the kinetic parameters of 
the processes can be obtained by simulation of cyclic voltammograms using Digisim 
software package (BAS).  
One of the chemical reactions in the catalytic process is described in Equation 11 with 
the forward rate constant k1, and the backward rate constant k-1, and the other is described 
in Equation 14 with rate constant k2. The electrochemical reactions include direct 
electroreduction of nitromethane, displayed in Equation 11, with the heterogeneous 
electron transfer rate constant kS1 and the catalytic electrochemical process given in 
Equation 13 with an electron transfer rate constant kS2. The simulated parameters are 
shown in table 2.3 using our proposed mechanism. 
By definition, k2 is equal to kcat and Km is equal to (k-1 + k2) / k1. The parameters of 
simulation k1, k-1, and k2 shown in Table 2.3 are in agreement with the Michaelis-Menten 
parameters kcat and Km listed in Table 2.1. The simulated voltammograms fit the 
experimental data properly and are shown in Figure 2.20. Digisim simulations validate 
the kcat and Km values derived from catalytic current data and further confirm our 
proposed mechanism of the heme-mediated catalysis. 
 
Table 2.3 Digisim® simulation parameters of myoglobin-catalyzed nitromethane 
electroreduction 
 k1 (s-1· M-1) k-1 (s-1) k2  (s-1) kS1 (cm/s) kS2 (cm/s) 
Myoglobin 1 × 104 0.1 20 3.8 × 10-7 0.01 
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Figure 2.20 Digisim® simulation of cyclic voltammograms. ( □ ) simulated 
voltammograms, (—) experimental voltammograms using the proposed mechanism. 
Cyclic voltammogram of Mb/DDAB/PG is obtained in the presence of 0.4 mM 
nitromethane in pH5.5 buffer solution at (a) 200 mV/s, (b) 400 mV/s, and (c) 600 mV/s.
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2.4 Conclusion 
Myoglobin can be used to study the catalytic activation of xenobiotic carcinogens 
such as nitromethane. The DDAB surfactant thin film method is suitable for 
metalloprotein immobilization. Myoglobin and cytochrome P450s share some common 
characteristics that come from the iron center of the porphyrin. Our mechanistic 
investigation showed the existence of a ferrous nitroso complex as the intermediate 
during Mb-mediated catalytic reduction of nitromethane. The product of Mb-mediated 
electroreduction of nitromethane is methyl hydroxylamine, and the catalysis is a 4-
electron process. The catalytic reduction process is examined under the experimental 
conditions such as scan rate, substrate concentration and pH. The kinetic information of 
the catalysis was extracted from our electrochemical experimental data. The Digisim 
software can be used to obtain the heterogeneous and homogeneous reaction rate 
constants using the cyclic voltammograms from our experiments. 
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CHAPTER III 
CATALYTIC ACTIVATION OF NITROMETHANE USING VARIOUS 
HEMOPROTEINS AND HEMIN 
 
3.1  Introduction 
 
The study of myoglobin-catalyzed nitromethane electroreduction gave us a general 
understanding of how hemoprotein can facilitate the electro activation of nitromethane. 
But what is the function of the protein parts of myoglobin, and whether there are 
differences between using myoglobin and using a real P450 enzyme in this catalytic 
process are still open questions. In this part of study, we use heme group without protein 
(hemin) and nitric oxide synthase (NOS), an enzyme that has a proximal cysteine thiolate 
akin to P450 enzymes, to catalyze the electroactivation of nitromethane and compare the 
results of myoglobin-mediated processes. Through the comparison, we may evaluate the 
effect of the protein shell and the effects of different heme ligands in different 
hemoproteins. 
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Hemin is the bare heme group and the prosthetic group in all heme proteins. It may 
have the catalytic properties of heme proteins without a protein shell (Figure 3.1). 
Understanding the intrinsic catalytic activation of nitromethane by hemin is of critical 
importance in order to better understand the role of the protein part of P450s. 
In the absence of protein structure, iron in hemin does not have the fifth ligand, 
therefore the ligand binding to heme and its open structure may bring different electron 
transfer, mass transport, and overall kinetics. Some studies reveal its ability to electro-
catalyze hydrogen peroxide, nitrite, nitric oxide, nitrous oxide, other nitro-compounds, 
and organic halides reduction. 1-5 
We also chose the nitric oxide synthase oxygenase (NOSoxy, Figure 3.2) to catalyze 
the electro-activation of nitromethane. Compared to hemin molecule, NOSoxy has the 
protein shell, and the heme group is held by a cysteine thiolate coordination at the 
proximal site just like P450 enzymes. Those differences could affect substrate 
accessibility and substrate binding affinity to the heme, therefore change the catalytic 
process. Also, the catalytic activation of nitroalkane needs protons, hence we can observe 
the effect of protein structure on proton transfer.  
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Figure 3.1 Structure of Hemin 
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Figure 3.2 Murine inducible nitric oxide synthase oxygenase domain with inhibitor 
Image from: PDB 1DF1 
 87
NOS is a very important enzyme responsable for nitric oxide biological production. 
Three isoforms of nitric oxide synthase are currently known; the family includes 
inducible NOS (iNOS), neuronal NOS (nNOS), and endothelial NOS (eNOS). We chose 
inducible NOS in our study, which is used by the immune system to produce NO to fight 
pathogens. 
 Full-length NOS enzymes are heme flavoproteins belonging to the P450 
superfamily 6. Their structure contains two domains on the same polypeptide: 1) an 
oxygenase domain, with specific binding sites for the heme active center, the 
tetrahydrobiopterin (BH4) cofactor, and arginine substrate 7, and  2) a reductase domain, 
which contains binding sites for nicotinamide adenine dinucleotide phosphate (NADPH), 
flavin adenine dinucleotide (FAD), and flavin mononucleotide (FMN) 7. 
Cytochrome P450 Reductase (CPR) and the NOS reductase domain both have the 
same prosthetic group FAD and FMN and the NADPH binding site.8 The oxygenase 
domain of NOS is also a heme-containing protein like cytochrome P450s. The biological 
functions of these two proteins are different but the basic catalytic functions of the 
functional groups are similar. FAD and FMN in reductase domain shuttle electrons from 
NADPH to heme group in oxygenase domain to activate heme, and the activated heme 
will perform the transition of substrate to product. Under aerobic condition, similar to 
other monooxygenases, NOS catalytic NO production is initiated by activation of 
molecular oxygen by NOS-heme to form an oxyferroheme complex9 (Scheme 3.1), just 
like cytochrome P450 (Scheme 1.1). So this enzyme can closely mimic cytochrome P450 
catalytic activity. 
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Scheme 3.1 Monooxygenation step of biological NO production by NOS9 
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In this study, we chose only oxygenase domain of NOS to study P450 enzyme 
activity because the electrons needed to activate heme are provided by the electrode. 
NOS enzymes structurally resemble the nitroalkane-metabolizing P450 enzymes, and 
nitroalkanes could be potential substrates for NOS too. Evidence shows that nitroalkanes 
or their metabolites such as hydroxylamines could interact with NOS-heme 10. 
Nitroalkane can also be oxidized by oxygen catalyzed by a flavoprotein 11. In addition, 
hydroxylamines have shown to have vasodilatory properties 12, 13, possibly through a 
metabolic path leading to NO release.  
In this work, hemin and NOS are immobilized on PG electrodes in DDAB thin film 
as we did with myoglobin in the previous study. The electrocatalysis is characterized 
electrochemically and the differences of enzymatic activities are discussed.  
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3.2 Experimental design 
 
3.2.1 Materials 
Hemin is purchased from Sigma and used without further process. 
Didodecyldimethyl-ammonium bromide (DDAB) and nitromethane are from Acros 
Organics. Oxygenase domain of inducible nitric oxide synthase (iNOSoxy) is expressed 
and purified in our laboratory. 
Nitrogen, compressed from PRAXAIR. Deionized water is obtained from a Barnstead 
Nanopure system with a resistivity greater than 18 MΩ · cm. Pyrolytic graphite 
(Advanced Ceramic) is the material for the working electrodes. Homemade working 
electrodes are prepared as in reference.5 
3.2.1.1 Expression and Purification of Recombinant iNOSoxy 
The expression and purification of the oxygenase domain is conducted in house using 
classic Escherichia coli expression systems. 
The experimental protocol that we use is for iNOSoxy expression has been described 
in the literature 14; it was adopted as such but with minor modification. Briefly, 
recombinant wild-type iNOSoxy proteins with a His6 tag attached to their carboxyl 
terminus are overexpressed in Escherichia coli strain BL21 (DE3) using a modified 
pCWori vector. The expression of the protein is typically induced when the culture 
reaches an optical density of 0.6 at 600 nm. The cells are harvested   after (12-24) hours 
induction and then suspended in the lysis buffer. After sonication, the suspension is 
centrifuged and the crude extract is loaded into a Ni-nitrilotriacetate-Sepharose 4B 
column. Bound protein was eluted with elution buffer (160 mM Imidazole, 10μM 
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H4B/AA, 1mM L-Arginine, 1mM PMSF/ethanol). The collected fractions containing 
iNOSoxy are then pooled and concentrated. The final concentrated protein solution is 
then dialyzed at 4°C to desalt and stored in aliquots (10% glycerol added) at -80°C.  
 
3.2.2 Electrode modification 
Hemin (Hm) or iNOSoxy is immobilized in the surfactant film on a basal-plane 
pyrolytic graphite (PG) disc electrode4, 15 (surface area is 0.08 cm2), and the modified 
electrodes are referred to as Hm/DDAB/PG and iNOSoxy/DDAB/PG. Before coating, the 
PG electrode is polished using 400 grit sandpaper followed by 0.3μm alumina. The 
polished electrode is then rinsed and sonicated in distilled water. Hm/DDAB surfactant 
film is prepared by casting 10μl Hm/DDAB surfactant solution on the PG electrode and 
dried in air for more than 12 hours. Hm/DDAB surfactant solution is prepared by mixing 
0.4 mM hemin solution with 10mM DDAB H2O emulsion is a 1:1 volume ratio. DDAB 
solution is prepared by dissolving DDAB powder in deionized water and sonicating for 2 
hours. Hemin solution is prepared by sonicating hemin in 0.1M acetate buffer (pH 5.5, 
0.05 M NaBr is added) for 2 hours to make a homogeneous dispersion. The hemin 
dispersion is mixed with DDAB emulsion immediately after sonication. iNOSoxy/DDAB 
surfactant film is prepared by casting 5μl of 10mM DDAB H2O solution followed by 5μl 
of iNOSoxy buffer solution. iNOSoxy buffer solution is prepared using the protocol 
described above. 
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3.2.3 Electrochemistry 
The electrochemical techniques used in this work are the same as in the previous 
study. The apparatus keeps the same. 
 
3.2.4 UV-Vis spectroscopy 
UV-Vis spectroscopy is used in this work to determine the concentration and 
structure character of iNOSoxy protein.  
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3.3 Results and discussion 
3.3.1 Spectroscopic characterization of iNOSoxy/DDAB film 
Prior to electrochemical measurements, we first studied whether the native form of 
iNOSoxy is conserved in the surfactant environment. To this end, we used UV-Vis 
spectroscopic characterization using the typical Soret band (Figure 3.3), as well as 
Fourier Transform Infrared Spectroscopy (FTIR) using the amide I and amide II IR bands 
(results not shown). A mixture of equal volumes of a purified sample of enzyme (~60 μM) 
and DDAB suspension (10 mM) is cast on transparent indium tin oxide (ITO) glass slide 
to prepare the iNOSoxy/DDAB film. As with graphite electrode preparation, the cast film 
on ITO is typically left to dry slowly in a closed vessel overnight, and then in open air. 
For iNOS heme domain, the typical low-spin iron-heme Soret bands is at around 422 nm 
16. Our results show that both iNOSoxy/DDAB on ITO slide and the control iNOSoxy in pH 
7 phosphate buffer show the characteristic Soret absorption at 421 nm, Figure 3.4. These 
results show that the native form of iNOSoxy is mainly conserved in the DDAB 
surfactant film. Also, addition of arginine, which binds above the Fe-heme at the active 
site switches the spin state of the iron center from low to high spin. This process can be 
easily monitored through a typical shift of the Soret band to about 396 nm. We observe 
similar shift with iNOSoxy immobilized in the bilayered DDAB film. This indicates 
clearly that the substrate arginine specifically recognizes its binding site in the film 
environment. These spectroscopic results show that the native structure of the embedded 
iNOSoxy enzyme is still conserved.  
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Figure 3.3 UV-vis absorption spectra of (a) iNOSoxy in buffer solution and (b) 
iNOSoxy/DDAB film on a transparent ITO slides. 
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To further confirm the native form of NOS in the DDAB environment, we analyzed 
the effect of DDAB on the position and shape of the amide I and amide II, which 
typically reflect the state of the secondary structure of globular proteins. To this end, we 
used FTIR spectroscopy on films cast on a diamond crystal. Our results show that the 
shape and position amide I and II are not affected by the presence of DDAB (results not 
shown).  
Together, our spectroscopic characterizations of iNOSoxy/DDAB films, confirm that 
the native structure of iNOSoxy in the surfactant thin film is conserved, and that the 
immobilized enzyme can still interact and recognize analytes added in the solution bulk. 
 
3.3.2 Electrochemistry of Hm/DDAB/PG, iNOSoxy/DDAB/PG, and Mb/DDAB/PG 
Figure 3.4 shows the voltammograms of Hm/DDAB/PG, iNOSoxy/DDAB/PG, and 
Mb/DDAB/PG in buffer solution. The direct electrochemistry of each electrode shows 
two fast and reversible redox couples that are characteristics of the heme redox centers.  
The formal potentials of FeIII/FeII and FeII/FeI redox couples for Hm/DDAB are –0.195V 
and –1.038V vs. Ag/AgCl respectively, for iNOSoxy/DDAB these couples are at              
–0.184V and –1.055V, respectively, and for Mb/DDAB these are found at  –0.180V and 
–1.052V. The iNOSoxy/DDAB results are comparable with Udit’s work using a similar 
experimental approach17. The difference in redox potential can be only due to the 
different residues or ligands in the heme vicinity of hemoprotein or hemin. 
Although we try to use the same concentration of heme (or protein) solutions to 
modify the electrodes, the surface concentration of heme group for each type of electrode 
will be different. As can be seen the reductive or oxidative peak area of FeIII/FeII redox 
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couple of the Hm/DDAB electrode is bigger than that of iNOSoxy/DDAB or Mb/DDAB 
electrode. The peak area is proportional to the amount of electroactive species in the film. 
Therefore, the surface concentration of heme for Hm/DDAB electrode is higher than that 
of iNOSoxy/DDAB or Mb/DDAB electrode. iNOSoxy/DDAB and Mb/DDAB electrodes 
show similar surface concentration of heme group. The difference in surface 
concentrations can be a problem when comparing the catalytic currents for different 
catalysts because the amount of catalyst that participates in the catalysis is not the same. 
To eliminate the effect of concentration differences, the catalytic current is normalized by 
dividing the catalytic peak by the reductive or oxidative peak area (or peak height if the 
peak widths are similar) of FeIII/FeII redox couple of the same electrode. It also eliminates 
the deviation among the same type of electrodes. 
To quantify total amount of active catalyst on the electrode surface we use the method 
described in previous study. The results show that The average values for Hm/DDAB and 
iNOSoxy/DDAB film are around 38.1 picomoles and 19.0 picomoles, respectively; 
accordingly the surface concentrations are 4.76 × 10-10 mole/cm2 for Hm/DDAB/PG and 
2.37 × 10-10 mole/cm2 for iNOSoxy/DDAB/PG. The average surface concentration of 
active heme for Mb/DDAB/PG is 2.65 × 10-10 mole/cm2 from previous research. 
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Figure 3.4 Cyclic voltammograms of heme(protein)-modified PG electrode in pH 5.5 
buffer at 0.15V/s.  (a) Hm/DDAB/PG, (b) Mb/DDAB/PG, and (c) iNOSoxy/DDAB/PG. 
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Not only the formal potentials and the amount of active heme are different for each 
heme (or protein), the electron transfer kinetics also differs between Hm/DDAB and 
Mb/DDAB. To compare the electron transfer kinetic of Hm/DDAB electrode within the 
film with that of Mb/DDAB electrode, cyclic voltammetry is conducted from 0.2V to –
0.6V for 2 continuous cycles, and only the second cycle of the voltammogram is used to 
obtain peak separation data (ΔEp) used in kinetic assessments. 
When we compare the 2 curves in Figure 3.5, we see that both ΔEp(Mb) and ΔEp(Hm) 
stay unchanged in the range of scan rate from 0.001V/s to 1V/s, indicating fast reversible 
electron transfer kinetics. The electron transfer tat is typically measured at the onset of 
the abrupt increase of ΔEps at high scan rates. Hemin shows higher ΔEp in every scan rate 
we tested. At the scan rate that is lower than 1V/s, the ΔEps of Hm/DDAB and 
Mb/DDAB are 50-60mV and 22-25mV, respectively. In the high scan rate (greater than 
1V/s) region, Hm/DDAB system displays increasing ΔEp with a relatively steeper 
increase than from Mb/DDAB electrode. These data suggest that Hm/DDAB have lower 
heterogeneous electron transfer rate than that of Mb/DDAB within the thin film.  
The same experiment with iNOSoxy/DDAB was performed. However, due to the 
poor stability of the protein film under the condition of extremely low scan rate, full set 
of data could not be obtained. Hence, the iNOSoxy/DDAB data was not included in the 
comparison above. 
 99
 
 
 
 
 
 
 
 
 
 
-3 -2 -1 0 1 2
50
100
150
200
(b)
ΔE
p m
V
log (v)
(a)
 
Figure 3.5 ΔEp as a function of scan rate. (a) Mb/DDAB/PG; (b) Hm/DDAB/PG 
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3.3.3 Comparison of iNOSoxy-mediated nitromethane electroactivation with 
myoglobin-mediated, and bare heme-mediated activations. 
3.3.3.1 Electroreduction of nitromethane by the different heme-based catalysts 
The Hm/DDAB and iNOSoxy/DDAB systems can also catalyze the electroreduction 
of nitromethane as Mb/DDAB did in the previous study. Figure 3.6A(b) shows the 
catalytic reduction peak Rc of Hm/DDAB at –0.964 V in the presence of 0.4 mM of 
nitromethane. As a bare hemin-mediated catalysis, the catalytic current of Hm/DDAB is 
the highest among the 3 catalysts. The high surface concentration of heme group is an 
obvious reason. However, once normalized with the amount of heme, Hm/DDAB still 
exhibits the highest turnover rate; this will be discussed later.  Figure 3.6B(b) shows the 
catalytic reduction peak Rc of iNOSoxy/DDAB at –1.060 V. It displays a notable higher 
catalytic current compared to the catalysis mediated by Mb/DDAB (Figure 3.6C) even 
with slightly lower amount of heme group in the film. The factor that contributes to this 
might be the protein structure difference; so the accessibility to heme for iNOSoxy may 
be easier than that of myoglobin. Therefore, the mass transport is faster in 
iNOSoxy/DDAB system than in Mb/DDAB.  
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Figure 3.6A Cyclic voltammograms of DDAB/PG and Hm/DDAB/PG electrode in pH 
5.5 acetate buffer solution at the scan rate 0.15V/s. (a) Hm/DDAB/PG without 
nitromethane, (b) Hm/DDAB/PG with 0.4 mM nitromethane, (c) DDAB/PG with 0.4 
mM nitromethane. 
Figure 3.6B Cyclic voltammograms of DDAB/PG and iNOSoxy/DDAB/PG electrode in 
pH 5.5 acetate buffer solution at the scan rate 0.15V/s. (a) iNOSoxy/DDAB/PG electrode 
without nitromethane, (b) iNOSoxy/DDAB/PG electrode with 0.4 mM nitromethane, and 
(c) DDAB/PG electrode with 0.4 mM nitromethane. 
 Figure 3.6C Cyclic voltammograms of DDAB/PG and Mb/DDAB/PG electrode in pH 
5.5 acetate buffer solution at the scan rate 0.15V/s. (a) Mb/DDAB/PG without 
nitromethane, (b) Mb/DDAB/PG with 0.4 mM nitromethane, (c) DDAB/PG with 0.4 mM 
nitromethane. 
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Some reports claim that the electronic signal from a hemoprotein modified electrode 
is from hemin that is released from hemoprotein. We already tested SDS denatured 
myoglobin electrode in the previous study, and here we apply the same treatment to a 
hemin-modified electrode, and the results are shown in Figure 3.7B. The electrochemical 
activity of Hm/DDAB (Figure 3.7A) is not changed with or without nitromethane 
substrate. Therefore, hemoproteins should be intact when being modified to PG electrode 
to perform catalysis. 
Some previous electrochemical investigations report on critical residues around the 
active site of hemoprotein.18 Also, a pH study of myoglobin-modified electrodes has 
shown that the electrochemical activity is closely related to the pkas of key residues of the 
protein.19-21 These results have showed that the protein and hydrogen-bonding network 
that it provides are involved in the electron transfer process. 
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Figure 3.7A Cyclic voltammograms of SDS denatured myoglobin electrode in pH5.5 
buffer. (a) 0 mM nitromethane (b) 0.4 mM nitromethane. 
Figure 3.7B Cyclic voltammograms of SDS treated hemin electrode in pH5.5 buffer. (a) 
0 mM nitromethane (b) 0.4 mM nitromethane. 
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3.3.3.2 The effect of nitromethane concentration 
We collected data from the experiments with iNOSoxy, hemin, and myoglobin, and 
plotted the normalized catalytic current as a function of substrate concentration 
(Michaelis-Menten plot, Figure 3.8) for these three different catalysts. The hyperbolic 
plot of each catalyst is then fitted into the electrochemical form of Michaelis-Menten 
equation (Equation 2.7) to obtain the parameters of kinetics. 
After data processing (Table 3.1), iNOSoxy shows the highest catalytic ability and the 
lowest catalyst-substrate dissociation constant Km for the catalytic reaction. On the 
contrary, hemin has the highest Km and highest turnover number Kcat (more than two 
times higher than that of iNOSoxy), but the overall catalytic ability is not better than 
iNOSoxy. iNOSoxy and myoglobin have similar catalyst-substrate stability, maybe 
because of the structural similarity of the substrate binding site of their heme centers. 
Hemin, on the other hand, lack the proximal fifth ligand and the protein shell, which may 
affect binding affinity and substrate accessibility to the heme iron. 
Table 3.1. Non-linear regression parameters from Figure 3.8 
 Km
(mM) 
kcat 
(s-1) 
kcat / Km
(s-1 · mM-1) 
Hemin 4.4 ± 0.5 68.3 ± 6.3 15.6 
iNOSoxy 1.7±0.2 28.1 ± 2.2 16.5 
Myoglobin 1.9 ± 0.2 20.9 ± 1.8 11 
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Figure 3.8 Normalized catalytic current as a function of substrate concentration. 
(Michaelis-Menten plot) (1) Hm/DDAB, (2) iNOSoxy/DDAB, and (3) Mb/DDAB. 
Icat’ is the catalytic current measured at the scan rat of 150 mV/s. 
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3.3.3.3 The effect of scan rate 
From the scan rate dependency studies of these three heme-based catalyst, one 
can see that NOS-mediated reaction has the steepest drop of catalytic efficiency 
compared to the hemin- and myoglobin-mediated ones in the scan rate range from 5mV/s 
to 1V/s, Figure 3.9. In the range from 1V/s to 20V/s, the catalytic efficiency of NOS or 
myoglobin-mediated reaction drops only slightly. The protein shell is iNOSoxy may play 
a role in the steep drop of catalytic efficiency in the 5 mV/s to 1 V/s range. In fact, 
protein shell controls substrate access to the active site, and thus directly affects mass 
transport. This is in line with the behavior of myoglobin, with relatively open active site 
compared to iNOSoxy, and which exhibits a moderate drop in catalytic current. At the 
other extreme, bare hemin, with a complete open access, exhibits only a gradual drop in 
catalytic current. 
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Figure 3.9 Catalytic efficiency as a function of scan rate. (1) Hm/DDAB/PG (2) 
iNOSoxy/DDAB/PG (3) Mb/DDAB/PG. 
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3.3.3.4 The effect of pH 
The pH dependency studies show clear proton dependency for hemin and heme-
protein-mediated catalysis, Figure 3.10. Hemin-mediated reaction exhibits the fastest 
dropping of catalytic efficiency with increasing pH, and NOS- or myoglobin-mediated 
reaction has a slower dropping rate. Literature suggests that the large number of hydrogen 
bonds within the protein molecule may provide extremely efficient means of proton 
transfer,22 and protonation and deprotonation of the amino acids surrounding the heme 
group of hemoprotein has been shown to affect proton coupled electron transfer 
process.19, 23-27 Also, the proton coupled electron transfer might be controlled by the 
protonation state of the amino acids23-25. The protein shell of iNOSoxy or myoglobin 
would also mediate proton transfers in this reaction, which could act as a local buffer 
counteracting the change in bulk pH and make the reaction relatively less dependent on 
pH, as observed. 
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Figure 3.10 Catalytic efficiency of nitromethane catalytic reduction as a function of pH 
in the presence of 0.1mM nitromethane mediated by (1) Hm/DDAB/PG, (2) 
iNOSoxy/DDAB/PG, and (3) Mb/DDAB/PG 
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3.3.4 Final products of hemin-mediated catalysis versus hemoprotein-mediated 
catalysis 
 Bulk electrolysis experiments coupled with mass spectrometric analysis as we used 
in the previous study show that the final product of hemin or myoglobin-mediated 
catalysis is methyl hydroxylamine. The number of electrons per nitromethane molecule in 
the electroreduction is close to 4 to 1 in both cases. The trials are shown in Table 3.2. 
We also did the experiment with iNOSoxy/DDAB electrode. Unfortunately, because 
of the vigorous convection applied in the bulk electrolysis, iNOSoxy/DDAB film was 
washed off quickly, and the experiment could not finish successfully. 
Table 3.2 The ratio of electron to nitromethane molecule 
  Total electrons passed 
Total nitromethane 
molecules reduced 
Electrons per 
molecule 
Trial 1 7.20 × 1018 1.54 × 1018 4.68 
Trial 2 7.33 × 1018 1.65 × 1018 4.44 Mb/DDAB 
Trial 3 7.62 × 1018 1.80 × 1018 4.23 
4.45 ± 
0.22 
Trial 1 7.12 × 1018 1.58 × 1018 4.51 
Trial 2 6.59 × 1018 1.41 × 1018 4.67 Hm/DDAB 
Trial 3 7.98 × 1018 1.81 × 1018 4.41 
4.53 ± 
0.13 
 
The results show that the final products of the electrocatalysis mediated by hemin or 
hemoprotein are the same. Therefore, the reaction mechanisms for these catalysts are 
likely the same as we proposed in last chapter with heme as the major player.  
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3.4 Conclusion 
iNOSoxy-mediated electroreduction of nitromethane shows highest catalytic ability 
close to the bare hemin-facilitated one. Low Km of iNOSoxy indicates a high heme 
binding affinity to a catalytically active form derived from the substrate. This is likely 
facilitated by the thiolate fifth ligand of heme and flanking residues around heme binding 
site. The scan rate dependency study shows that the protein shells of myoglobin and 
iNOSoxy control the mass transfer to the active site. Furthermore, the pH dependency 
study implies that the residues close to the heme binding site may mediate proton transfer 
or act as proton donors to assist the catalytic transformations.  
Comparing electroactivation of nitromethane catalyzed by two distinct hemoprotein 
and bare hemin illustrates the effects caused by the protein shell and iron ligation as well 
as the effects caused by residues around the heme site.  
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CHAPTER IV 
CATALYTIC ELECTROREDUCTION OF ALIPHATIC NITROALKANES 
MEDIATED: A COMPARATIVE STUDY OF INOSOXY AND HEMIN AS  
HEME-CATALYSTS 
 
4.1  Introduction 
Most nitroalkanes are toxic,1 and some are even found to be carcinogenic2-6 and 
genotoxic7. Nitromethane is an example of nitroalkanes that are potent carcinogens.8 Also, 
1-nitropropane has demonstrated mutagenic activity7, 9, 10 in cells though no link to 
carcinogenicity has been established even with chronic exposure.9 Some of the secondary 
nitroalkanes such as 2-nitrobutane and 3-nitropentane may cause significant incidence of 
hepatocarcinoma with metastasis in the lungs, and have also been found to be more 
carcinogenic than their corresponding primary nitroalkanes.11 2-nitropropane is another 
well-known hepatocarcinogen,12-14 and its mutagenicity has been studied widely using 
animal models.10, 15-18  
The types of cancer caused by nitroalkanes are different for, but the key step in each 
carcinogenic process always involves a biotransformation of the nitroalkane into a more 
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reactive compound. One possible metabolic pathway could be anaerobic nitro-reduction 
catalyzed by cytochrome P450 xenobiotic metabolizing enzymes through electron 
transfer producing alkyl hydroxylamines as the final product. This is in agreement with 
some research of the anaerobic metabolism of nitro compounds using biological 
samples.19, 20  
Previously we tested nitromethane anaerobic electroreduction mediated by myoglobin, 
hemin, and iNOSoxy. Our results indicate that electro-activation of nitromethane can be 
catalyzed by hemin or hemoproteins, and the catalytic function of the heme may reflect 
the metabolic pathway of nitromethane activation by P450 metabolizing enzymes under 
anaerobic conditions. Mass spectroscopy shows that the catalytic reduction of 
nitromethane under these conditions reduces the nitro group to hydroxylamine, possibly 
through our proposed pathway, Scheme 4.1. Hence, we propose that nitroalkanes with 
different alkyl groups may also be catalytically reduced to hydroxylamines through a 
similar catalytic mechanism. 
 
 
 
 
 
 
 
CH3    N 
O 
Heme(FeII) 
+ Heme(FeII) 
CH3NO2
+ 2 e- + 2 H+
CH3NHOH  
+ 2 e- + 2 H+  
CH3N=O  
- H2O  
- Heme(FeII)
 Scheme 4.1 Proposed heme-catalyzed electroreduction of nitromethane  
 
The size of the alkyl group might affect the mass transport in diffusion-controlled 
electrochemical techniques such as cyclic voltammetry. The different alkyl groups in 
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nitroalkanes may also affect the chemical properties of their nitro groups, therefore 
exhibiting effects on catalytic reduction. Because of these potential changes in chemical 
properties, we examined four different substrates in this study, nitromethane, nitroethane, 
1-nitropropane, and 2-nitropropane, Scheme 4.2.  
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Scheme 4.2 Structures of the nitroalkanes used in the study 
In this part, the various nitroalkanes are tested on Hm/DDAB/PG and 
iNOSoxy/DDAB/PG electrodes, and catalytic currents from cyclic voltammetry are used 
as the expressions of the catalysis. Mass spectrometry is used to identify the products of 
heme-mediated electroreduction of these 4 nitroalkanes. The catalytic efficiencies of 
different substrates are contrasted and effects of factors such as substrate concentration, 
scan rate of cyclic voltammetry, and pH, are discussed. 
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4.2  Experimental design 
4.2.1 Material 
Hemin, Nitromethane, Nitroethane, 1-Nitropropane, and 2-nitropropane are 
purchased from Sigma and used without further process. Didodecyldimethyl-ammonium 
bromide (DDAB) is from Acros Organics. Oxygenase domain of inducible nitric oxide 
synthase (iNOSoxy) is expressed and purified in our laboratory using the procedure 
described in chapter 3. 
Nitrogen, compressed from PRAXAIR. Deionized water is obtained from a Barnstead 
Nanopure system with a resistivity greater than 18 MΩ · cm. Pyrolytic graphite 
(Advanced Ceramics) is the material for the working electrodes. Homemade working 
electrodes are prepared as in reference.21 
4.2.2 Methods 
The hemin and iNOSoxy modification of electrodes have been described in chapter 3. 
Electrochemical techniques employed and the apparatus are the same as chapter 2. 
Bulk electrolysis is performed at -1.0 V vs. Ag/AgCl under constant stirring for 1 
hour. A large surface PG electrode modified with Hm/DDAB or iNOSoxy/DDAB is used 
as a working electrode. The starting concentration of nitroalkane is 1.96 mM in 5 mL of 
solution, and the concentration of nitroalkane after the electrolysis is estimated using an 
electrochemical method. The consumption of nitroalkane is derived from the difference 
between the initial amount and final amount. The total charge passed during the 
electrolysis is recorded. The total number of electrons per nitroalkane molecule can 
therefore be calculated. 
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A mass spectrometric method is employed to identify the product after the bulk 
electrolysis. The solution after electrolysis is infused into an electro spray ionization 
triple quadrupole (ESI-QQQ) mass spectrometer (Micromass Quattro II). The product is 
identified by the m/z ratio on the mass spectrum. 
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4.3  Results and discussion 
4.3.1 Direct electroreduction of nitroalkanes on a DDAB/PG and catalytic 
electroreduction of nitroalkanes mediated by Hm/DDAB/PG and 
iNOSoxy/DDAB/PG  
Figure 4.1 shows the electroreduction of nitroalkanes on DDAB/PG electrodes. Since 
there is no catalyst involved, we label these processes as direct reductions or non-
mediated reductions. The reduction current response for the various nitroalkanes are in 
the order of nitromethane > nitroethane > 1-nitropropane > 2- nitropropane, and the 
reductive potentials from positive to negative are 1-nitropropane (-1.133 V), 
nitromethane (-1.195 V), nitroethane (-1.217 V), and 2- nitropropane (-1.221 V). The 
hemin-mediated catalytic reductions (Figure 4.2) show that the current intensities are in 
the same order of that of direct reduction, and the potential from positive to negative 
follows the order 1-nitropropane (-0.972 V), 2-nitropropane (-0.979 V), nitromethane (-
1.001 V), and nitroethane (-1.042 V). The reduction currents of iNOSoxy-mediated 
reactions (Figure 4.3) follow the same order as the direct reductions, and the reduction 
potentials also show the same order as for the direct reductions but at much positive 
potentials: 1-nitropropane (-1.024 V), nitromethane (-1.049 V), nitroethane (-1.056 V), 
and 2-nitropropane (-1.058 V). In addition, the potentials of iNOSoxy-mediated 
electroreductions are very close to each other. 
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Figure 4.1 Cyclic Voltammograms of DDAB/PG electrode in pH 5.5 buffer at 150 mV/s 
in the presence of nitroalkanes. (a) 0.2 mM nitromethane, (b) 0.2 mM nitroethane, (c) 0.2 
mM 1-nitropropane, and (d) 0.2 mM 2-nitropropane. 
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Figure 4.2 Cyclic Voltammograms of Hm/DDAB/PG electrode in pH 5.5 buffer at 150 
mV/s in the presence of nitroalkanes. (a) 0.2 mM nitromethane, (b) 0.2 mM nitroethane, 
(c) 0.2 mM 1-nitropropane, and (d) 0.2 mM 2-nitropropane. 
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Figure 4.3 Cyclic Voltammograms of iNOSoxy/DDAB/PG electrode in pH 5.5 buffer at 
150 mV/s in the presence of nitroalkanes. (a) 0.2 mM nitromethane, (b) 0.2 mM 
nitroethane, (c) 0.2 mM 1-nitropropane, and (d) 0.2 mM 2-nitropropane. 
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The current intensities of direct electroreductions on the DDAB/PG and the heme-
facilitated electroreduction (Figure 4.2 and Figure 4.3) exhibit the same trend in that 
smaller nitroalkanes have higher catalytic currents. An obvious reason is that the 
diffusion that controls mass transport plays to the advantage of small molecules, Table 
4.1. To see the effect of molecular size of the nitroalkane substrate, we examined and 
compared the effect of scan rate of catalytic reduction of the various nitroalkanes.  
Table 4.1 Hydrodynamic radiuses of the alkyl groups22 
 methyl ethyl propyl isopropyl 
r (nm) 0.20 0.225 0.25 0.30 
 
For heme-mediated reduction of the four nitroalkane substrates, the reduction peaks 
in the voltammograms all shift to positive potentials compared to the direct reductions. 
The same is true for hemin-mediated catalysis but the current intensities are relatively 
larger. The shift of the reductions to positive potentials and the increase of reaction rate 
are typical features for electrocatalytic process. Therefore, hemin and iNOSoxy are 
efficient electrocatalysis for the electroreductions of the 4 nitroalkane substrates.  
The direct reduction potentials follow the order of nitromethane, nitroethane, and 2- 
nitropropane. This trend may be explained by the inductive and hyperconjugative effects 
of alkyl groups.23 Alkyl groups are considered as electron-donating to the nitro group, 
and the inductive effect (+I) follows the order -CH3 < -CH2CH2CH3 < -CH2CH3 < -
CH(CH3)2. The effect increases the negative charge on the nitro group therefore make the 
reduction more difficult. However, 1-nitropropane is unique among the 4 substrates. It 
shows the most positive potential in both direct electroreduction and heme-mediated ones. 
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A possible reason is that the reduction of 1-nitropropane, with the smallest dielectric 
constant among the 4 nitroalkanes, is favorable on our electrodes modified with 
hydrophobic DDAB films. Stabilized intermediates derived from this nitroalkane relative 
to the other 3 substrates may also play a role in these reductions at positive potentials. 
One may notice that the hemin-mediated 2-nitropropane displays the largest shift of 
reduction potential from –1.221 V to –0.979 V among all the nitroalkane substrates. The 
hemin catalyst in the reaction lowers the activation energy of 2-nitropropane reduction 
more than those of the other 3 substrates. It is possible that in the heme-mediated 
reduction, 2-nitropropane forms the hemin ferrous 2-nitrosopropane complex that can be 
reduced at low potential, and the mediation by hemin may also compensate for the 
inductive effects that makes 2-nitropropane hard to reduce. 
4.3.2 Identification of the products of the hemin-mediated electroreduction of 
nitroalkanes 
It is critical to know the products of the catalytic electroreduction and number of 
electrons consumed per substrate molecule so that the mechanism of the catalysis can be 
derived. To find out the ratio of electron to nitroalkane molecules, we perform bulk 
electrolysis using each of the 4 nitroalkane substrates.  From the total electrons passed 
and total amount of nitroalkane consumed, one can calculate the electrons per molecule. 
The results of this work are listed in Table 4.2. The products of catalytic electroreduction 
of nitroalkanes are identified by mass spectrometry (Figure 4.4) using the solution after 
bulk electrolysis (Table 4.3).  
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Table 4.2 The ratio of electron to nitroalkane molecule 
 Total electrons 
passed 
Total molecules 
reduced 
Electrons per 
molecule 
nitromethane 8.45 × 1018 1.93 × 1018 4.38 
nitroethane 7.15 × 1018 1.69 × 1018 4.23 
1-nitropropane 7.54 × 1018 1.81 × 1018 4.17 
2-nitropropane 7.07 × 1018 1.63 × 1018 4.34 
 
Table 4.3 The products of catalytic electroreduction of nitroalkanes 
 The products of catalytic electroreduction 
nitromethane methyl hydroxylamine (CH3-NHOH) 
nitroethane ethyl hydroxylamine (C2H5-NHOH) 
1-nitropropane propyl hydroxylamine (C3H7-NHOH) 
2-nitropropane isopropyl hydroxylamine ((CH3)2C-NHOH) 
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Figure 4.4A Mass spectra of 2 mM nitromethane in the buffer solution (a) before and (b) 
after the bulk electrolysis. 
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Figure 4.4B Mass spectra of 2 mM nitroethane in the buffer solution (a) before and (b) 
after the bulk electrolysis. 
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Figure 4.4C Mass spectra of 2 mM 1-nitropropane in the buffer solution (a) before and 
(b) after the bulk electrolysis. 
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Figure 4.4D Mass spectra of 2 mM 2-nitropropane in the buffer solution (a) before and 
(b) after the bulk electrolysis. 
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Since the mass spectrometric results show that the reduction products of nitroalkanes 
are exclusively the corresponding alkyl hydroxylamine, and the ratio of electrons to 
nitroalkane molecules is close to 4 for each substrate, the possible mechanism of the 
catalysis may be similar to Scheme 4.1. We can therefore describe the electroreductions 
by the following generalized scheme (Scheme 4.3). 
 
 
 
  
 
 
R    N 
O 
Heme(FeII) 
+ Heme(FeII) 
RNO2 
+ 2 e- + 2 H+
RNHOH  
+ 2 e- + 2 H+  
RN=O   
- H2O  
- Heme(FeII)
 
 Scheme 4.3 Heme-catalyzed electroreduction of nitroalkanes 
 
 
4.3.3 The effect of substrate concentration  
The catalytic current increases as the concentration of substrate increases, Figure 4.5. 
One can see that the first redox couple FeIII/FeII, which is caused by the surface confined 
hemin is not affected by the addition of nitroalkanes. Therefore, we can use the reductive 
wave of I0 as an indication of the amount of hemin in the film. To eliminate the effect 
that is caused by the slight difference among electrodes, we use the ratio of Icat / I0 and 
referred it as catalytic efficiency. This way we can compare the catalysis of different 
nitroalkanes with different electrodes. From the plot of catalytic efficiencies as functions 
of substrate concentration, Figure 4.6 and Figure 4.7, one can see that the catalytic 
efficiencies increase steadily at low concentrations and tend to reach maximum at high 
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concentrations. This catalysis saturation behavior fits Michaelis-Menten enzyme kinetics, 
Equation 4.1. 
][
][max
SK
SVV
m +
×=   (Michaelis-Menten Equation)   (4.1) 
Since we use the normalized catalytic current, Icat / I0, as the measurement of the 
velocity of the reaction, Figure 4.6 and 4.7 can be treated as Michaelis-Menten plot. To 
obtain the kinetic parameters of the catalyst, we perform the non-linear regression using 
Michaelis-Menten equation and we can estimate the Km values for each substrate and 
each catalyst system, Table 4.4. 
Table 4.4 Km values of hemin and iNOSoxy for different nitroalkane substrates from the 
non-linear regression of the Mechaelis-Menten plots 
  nitromethane nitroethane 1-nitropropane 2-nitropropane 
Km (mM) 4.4 ±0.50 4.04 ±0.25 6.03 ±0.39 6.11 ±0.69 
kcat (s-1) 68.3 ± 6.3 55.6 ± 4.8 45.8 ± 3.7 39.5 ± 4.1 Hemin 
kcat/Km  
(s-1·mM-1) 15.6 13.8 7.6 6.5 
Km (mM) 1.81±0.17 2.14±0.31 2.06±0.12 2.76±0.29 
kcat (s-1) 28.1±2.2 26.3±1.9 23.1±1.7 20.7±1.6 iNOSoxy 
kcat/Km  
(s-1·mM-1) 16.5 12.3 11.2 7.5 
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Figure 4.5 Cyclic voltammograms (a) 0 mM, (b) 0.3 mM, (c) 0.8 mM, (d) 1.3 mM, and 
(e) 2.0 mM of nitromethane electroreduction mediated by Hm/DDAB/PG in pH 5.5 
buffer at 0.15 V/s. 
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Figure 4.6 Catalytic efficiency as a function of nitroalkane concentration for 
Hm/DDAB/PG electrode. (a) nitromethane (b) nitroethane (c) 1-nitropropane (d) 2-
nitropropane 
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Figure 4.7 Catalytic efficiency as a function of nitroalkane concentration for 
iNOSoxy/DDAB/PG electrode. (a) nitromethane (b) nitroethane (c) 1-nitropropane (d) 2-
nitropropane 
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Comparing the Km of nitroalkane substrates in hemin-catalyzed reduction, 
nitromethane and nitroethane have similar smaller values, whereas 1-nitropropane and 2-
nitropropane both have relatively larger values. Steric effects may contribute to this trend. 
Therefore, the larger Km can be rationalized by the steric hindrance caused by the larger 
alkyl groups in the substrate-catalyst interaction process. This effect may cause a 
difference between smaller and larger nitroalkanes or between straight versus branched 
nitroalkanes because of their different geometric arrangements. This observation is 
consistent with previous reports that indicate the formation rate of the heme ferrous 
nitrosoalkane in solution is slower for larger nitroalkanes such as 2-nitropropane.24 
The other Michaelis-Menten parameter kcat can be obtained by non-linear regression 
of the Michaelis-Menten plot using the electrochemical format of Michaelis-Menten 
equation, as described in Chapter 2. The kcat and the kcat/Km of each substrate indicate that 
hemin can catalyzed the electroreduction of smaller nitroalkane more efficiently than 
larger ones, and linear nitroalkane 1-nitropropane has higher turnover rate than the 
branched one. 
In both case of hemin and iNOSoxy-mediated activation of different nitroalkanes, the 
catalytic efficiency follows the order: nitromethane > nitroethane > 1-nitropropane > 2-
nitropropane, Figure 4.6 and 4.7, Our results suggest that the smaller the nitroalkane, the 
higher the catalytic efficiency. In addition, branched nitroalkanes show slightly lower 
rates of catalysis than their linear counterparts.  
The Km constants of nitroalkanes electroreduction for hemin as a catalyst are 
significantly larger than that for iNOSoxy. The proximal thiolate ligand of the iNOSoxy 
heme group help stabilize the trans-ligand, and the flanking residues around the binding 
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site also facilitate the binding of intermediates during turnover. These conditions are not 
met for bare hemin and thus large Km value results. 
 
4.3.4 The effect of scan rate  
Scan rate of cyclic voltammetry defines the timescale within which the catalytic 
reaction is observed as well as substrate and product transports by diffusion. Increase of 
scan rate shortens the timescale and the catalysis is monitored very early in the process 
(less catalytic turnovers). As we seen in Figure 4.8, Ica /I0 decreases with logarithm of 
scan rate. Catalytic efficiencies of hemin-mediated electroreduction as a function of scan 
rate (Figure 4.8) shows the same trend for all the substrates, and within the same range of 
scan rate, the catalytic efficiencies of the 4 substrates follows the order nitromethane > 
nitroethane > 1-nitropropane > 2-nitropropane. Therefore, the size of the substrate 
molecule plays an important role in the catalysis. More of this will be discussed when we 
present our results of digital simulation of the catalytic process. 
The catalytic efficiencies of iNOSoxy-mediated reduction of nitroalkane substrates 
show the expected decreasing trend with increasing scan rate, Figure 4.9. At low scan 
rate region (<1 V/s), the catalytic efficiencies of iNOSoxy-mediated reductions decrease 
faster than the efficiencies of the same reaction catalyzed by hemin. From scan rate 1V/s 
to 20V/s, the catalytic efficiency only exhibits only a slight decrease for all 4 substrates.  
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Figure 4.8 Catalytic efficiency as a logarithmic function of scan rate for Hm/DDAB/PG 
in pH5.5 buffer in the presence of 0.2 mM nitromethane. (a) nitromethane (b) nitroethane 
(c) 1-nitropropane (d) 2-nitropropane 
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Figure 4.9 Catalytic efficiency as a logarithmic function of scan rate for 
iNOSoxy/DDAB/PG in pH5.5 buffer in the presence of 0.2 mM nitromethane. (a) 
nitromethane (b) nitroethane (c) 1-nitropropane (d) 2-nitropropane 
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4.3.5 The effect of pH  
The catalytic electroreduction of nitroalkane is a 4-electron 4-proton process. The 
proton availability will obviously affect the efficiency of the catalysis. As seen in Figure 
4.10 and Figure 4.11, catalytic efficiencies decrease with increasing pH. However, the 
trend of decrease for each substrate is irregular and unique, pointing to other factors that 
affect the catalytic reduction at different pHs other than proton availability. 
Nitroalkanes are polar and slightly acidic in aqueous medium. Primary and secondary 
nitroalkanes can dissociate into nitronate anions and protons, Equation 4.2. The aci-nitro 
tautomerism of nitroalkane shows the equilibria of nitronic acid, R1R2C=NO2H (aci form), 
nitroalkane, and the nitronate anion R1R2C=NO2- in neutral or basic medium, Equation 
4.3.25  
 
R1R2CH-NO2 + H2O   R1R2C=NO2- + H3O+   (4.2) 
k1 
k-1 
 
R1R2C=NO2H       R1R2C=NO2- + H+        R1R2CH-NO2 (4.3) 
k-1 
k1 
k2 
k-2 
 
Because of the intramolecular proton transfer, the nitro group can transform into 
several other functional groups. These unique chemical properties may play a role in the 
catalytic electroreduction of nitroalkanes. As shown in Nielsen’s work,25 pH is closely 
related to the tautomerization (equation 2) of nitroalkanes. Since the nitronate anion of 
nitroalkane is not electro reducible,25 the ionization of nitroalkane should have an effect 
on the electroreduction. The ionization constant pKanitro (Ka= k1/k-1) and pKaAci (Ka= k2/k-2) 
for different nitroalkanes reported by Nielsen25 are in Table 4.5. 
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Table 4.5 Ionization constant of nitroalkanes and nitronic acids in water25 
nitroalkane pKanitro pKaAci
nitromethane 10.21 3.25 
nitroethane 8.5 4.4 
1-nitropropane 8.98 4.6 
2-nitropropane 7.68 5.1 
 
Since the ionization is much weaker for the nitro form of nitroalkane than the aci 
form, the catalytic efficiency in acidic and neutral media would not be affected too much 
by the ionization of nitroalkanes. However, in basic media, nitroalkanes will transform to 
nitronic acids and make the electroreduction process difficult. For hemin-mediated 
reductions, Figure 4.10a shows nitromethane having the sharpest decrease from pH 9 to 
pH 10.5, and the catalytic efficiency declining slopes (pH >9) follow the order 
nitromethane > nitroethane > 1-nitropropane > 2-nitropropane. This order fits the pKaAci 
values of the aci form nitroalkanes. 
We also tested the iNOSoxy-mediated catalytic reduction in the pH range from 5.35 
to 10.00. The trends of the catalytic electroreduction for all the nitroalkane substrates 
were similar. Results show that while iNOSoxy-mediated catalytic reductions are 
dependent on protons, the dependence is less pronounced compared to hemin-mediated 
catalysis. The protein shell of iNOSoxy very likely plays a role in mediating proton 
transfers, which could act as a local buffer counteracting the change in bulk pH.  
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Figure 4.10 Catalytic efficiency as a function of pH for the nitroalkane electroreduction 
on Hm/DDAB/PG electrodes. (1) 0.2 mM nitromethane, (2) 0.2 mM nitroethane, (3) 0.2 
mM 1-nitropropane, and (4) 0.2 mM 2-nitropropane. 
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Figure 4.11 Catalytic efficiency as a function of pH for the nitroalkane electroreduction 
on iNOSoxy/DDAB/PG electrodes. (1) 0.2 mM nitromethane, (2) 0.2 mM nitroethane, (3) 
0.2 mM 1-nitropropane, and (4) 0.2 mM 2-nitropropane. 
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4.3.6 Estimation of heterogeneous and homogeneous reaction rates 
To further shed light on the mechanism and to assess the kinetics of catalytically 
initiated steps, we decided to carry out digital simulation of the voltammetric response of 
each substrate and catalytic system.  
 To test our working mechanism of heme-mediated nitroalkane electroreduction for 
all four substrates, we used digital simulation to calculate voltammetric response and fit 
our experimental data. We only show the results of hemin-mediated reduction. 
The heme-mediated electroreduction of nitroalkanes involves multiple steps of 
chemical and electrochemical reactions as proposed in our previous study, and can be 
generalized as shown in Equation 4.4 to 4.7. The rate constant of each step can be 
adjusted in the program until a satisfactory fit to experimental data is achieved. The 
results from the simulations are tabulated in Table 4.6. The detailed simulation procedure 
is showed in Chapter 2. The simulated voltammograms are shown in Figure 4.12. 
 
R-NO2 + 2 e- + 2 H+    R-N=O + H2O    (direct reduction)  (4.4) 
kS1
 
  
 
   + 2 e- + 2 H+        (4.6) 
 
 
 
 
kS2N R    
O 
Heme(FeII) 
R    N 
OH 
Heme(FeII) 
H 
R    N 
OH 
Heme(FeII) 
H 
k2f
Heme(FeII) + R-NHOH   (4.7) 
(4.5) R    N 
O 
k1f
k1b
R-N=O + Heme(FeII) 
Heme(FeII) 
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Figure 4.12 Digisim® simulation of cyclic voltammograms. (∎) simulated 
voltammogram, (―) experimental voltammogram 
(a) Cyclic voltammogram of Hm/DDAB/PG in the presence of 0.4 mM nitromethane at 
(1) 200 mV/s, (2) 400 mV/s, and (3) 600 mV/s. 
(b) Cyclic voltammogram of Hm/DDAB/PG in the presence of 0.4 mM nitroethane at (1) 
200 mV/s, (2) 400 mV/s, and (3) 800 mV/s. 
(c) Cyclic voltammogram of Hm/DDAB/PG in the presence of 0.4 mM 1-nitropropane at 
(1) 200 mV/s, (2) 400 mV/s, and (3) 800 mV/s. 
(d) Cyclic voltammogram of Hm/DDAB/PG in the presence of 0.4 mM 2-nitropropane at 
(1) 200 mV/s, (2) 400 mV/s, and (3) 800 mV/s. 
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Table 4.6 Digisim® simulation parameters of hemin-catalyzed nitroalkane 
electroreductions. 
 k1f (s-1· M-1) k1b (s-1) k2f  (s-1) kS1 (cm/s) kS2 (cm/s) 
nitromethane 2 × 104 20 70 3.8 × 10-7 0.01 
nitroethane 2 × 104 25 55 3.3 × 10-7 0.01 
1-nitropropane 1.5 × 104 44 46 2.5 × 10-7 0.01 
2-nitropropane 1.5 × 104 50 40 2.1 × 10-7 0.01 
 
For all the substrates, the direct electroreduction of nitroalkane is sluggish (kS1 is in 
10-7 range), whereas the hemin-mediated electroreduction is fast (the rate constant kS2 is 
0.01).  It is common for a catalyzed reaction. The catalyst-substrate complex formation 
rate k1f for smaller nitroalkanes (CH3NO2 and CH3CH2NO2) is faster and slower for the 
larger ones. The catalyst-substrate complex dissociation rate k1b follows the order 
nitromethane<nitroethane<1-nitropropane<2-nitropropane. The simulation results nicely 
agreed with the arguments that in our previous discussion. 
In addition, the results showed that the reaction rate of each step can fit perfectly to 
the Michaelis-Menten parameters (Table 4.4) as we know that by definition, k2f is equal 
to kcat and Km is equal to (k1b + k2f) / k1f.  To show the relationship between Mechaelis-
Menten parameters and reaction rate constants, we put the results from digital simulation 
and the results from Mechaelis-Menten analysis side by side in Table 4.7.  
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 Table 4.7 The parameters derived from digital simulation and non-linear regression of 
Mechaelis-Menten plots. 
 Digital simulation Mechaelis-Menten analysis 
 k1f (s-1· M-1) k1b (s
-1) k2f  (s-1) Km (mM) kcat (s-1) 
nitromethane 2 × 104 20 70 4.4 ±0.50 68.3 ± 6.3 
nitroethane 2 × 104 25 55 4.04 ±0.25 55.6 ± 4.8 
1-nitropropane 1.5 × 104 44 46 6.03 ±0.39 45.8 ± 3.7 
2-nitropropane 1.5 × 104 50 40 6.11 ±0.69 39.5 ± 4.1 
 
Digital simulation of heme-mediated electroreduction of nitroalkanes confirms our 
generalized mechanism of electrocatalysis. In addition, the rate constants of elementary 
steps of the electroreduction as derived from digital simulations over a range of scan rate 
agree very well with the numbers found for kcat and Km derived from simple Mechaelis-
Menten analysis. 
Simulated catalytic efficiency is obtained by dividing the simulated catalytic current 
(using a proposed mechanism scheme) by the simulated hemin(FeII) current without 
substrate. The simulated catalytic efficiency as a function of scan rate result is shown in 
Figure 4.13. The simulated curve fits our experimental data well as shown in Figure 4.13. 
This great fit of simulated curve to experimental data over a range of scan rates is an 
indication of the validity of the proposed mechanism as reported in the previous section. 
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Figure 4.13 Simulated scan rate dependency curve with experimental data (a) 
nitromethane (b) nitroethane (c) 1-nitropropane (d) 2-nitropropane 
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 4.4 Conclusion 
Mass spectrometry shows that heme-mediated electroreductions of nitromethane, 
nitroethane, 1-nitropropane and 2-nitropropane produce the corresponding alkyl 
hydroxylamines as the final product. The intrinsic properties of aliphatic nitroalkanes 
affect their electroreduction process. The potential of catalytic peak differences among 
the various nitroalkanes seem to match inductive effect of alkyl groups connected to the 
nitro group. The size and shape of the substrate have a clear effect on the turnover rate. 
Smaller nitroalkanes exhibit higher turnover rates as compared to the larger ones. The Km 
value of hemin catalyst for each nitroalkane substrate indicates the stability of the 
catalyst-substrate intermediate complex, which is likely, a heme-nitrosoalkane complex; 
smaller nitroalkanes such as nitromethane and nitroethane exhibit higher stability. The 
study of pH catalysis dependency shows that the catalytic reduction is affected by the 
intrinsic ionization of the nitronic acid. Digisim simulations of cyclic voltammograms not 
only estimate the reaction rate of each elementary step of our proposed mechanism of the 
electrocatalysis, but also reinforce and validate the parameters derived from non-linear 
regression fitting of Michaelis-Menten plots. 
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Appendix A 
 
 
Cyclic Voltammetry 
Cyclic voltammetry (CV) is a potentiodynamic electrochemical technique. In a 
cyclic voltammetry experiment the working electrode potential is scanned linearly versus 
time as shown in the potential waveform plot. When the scan reaches a set point of 
potential, the potential scan is inverted. This inversion can be set multiple times during 
one single experiment. The current passing through the working electrode is recorded 
versus the potential applied to give the cyclic voltammogram. The waveform and 
resulting voltammogram is shown in Figure A1. 
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Figure A1 Waveform and resulting voltammogram of cyclic voltammetry (CV) 
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 Appendix B 
 
 
Demonstration of fabricating PG working electrodes 
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Figure B Fabrication of the PG working electrode. 
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Appendix C 
 
 
DigiSim® simulation 
DigiSim is a simulation software developed by BASi for cyclic voltammetry. 
DigiSim can be used to simulate any electrochemical mechanism that can be expressed in 
terms of single or multiple electron transfer reactions and first- and second-order 
homogenous reactions. In addition, DigiSim can generate dynamic concentration profiles 
and can fit simulated data to imported experimental data.1 
 
Mechanism used to fit our cyclic voltammogram: 
CH3NO2 + 2e = CH3NO 
FeII + CH3NO = FeIICH3NO 
FeIICH3NO + 2e = FeIICH3NHOH 
FeIICH3NHOH = FeII + CH3NHOH 
FeII + e = FeI
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Copyright © Bioanalytical Systems, Inc. 
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